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ABSTRACT 
 
Left ventricular (LV) noncompaction is characterized by the presence of an 
extensive trabecular myocardial layer within the luminal aspect of the compact 
myocardium of the ventricular wall. The trabeculae are both excessive in number and 
more prominent than normal. Noncompaction may occur in isolation usually with 
clinical features of dilated cardiomyopathy, or it may be associated with congenital or 
acquired heart diseases. Echocardiography is the reference standard for diagnosis, 
where a ratio of thickness of trabecular-to-compact myocardium (compaction ratio) of 
>2 is a major diagnostic criterion. Noncompaction is usually considered to result from 
persistence of the highly trabeculated myocardium found in early cardiogenesis of 
the human embryo. If persistence of excess trabeculae is the only determinant of the 
compaction ratio it would be expected that it would remain a consistent measurement 
in postnatal life. However, temporal changes in the degree of noncompaction in 
individual case reports have raised the question as to whether the compaction ratio 
might be sensitive to haemodynamic or other factors. 
 In the present dissertation, I assessed echocardiographically whether the 
compaction ratio is associated with increases in indices of LV volume preload in 100 
children or adolescents with ventricular septal defects (VSD), and 36 with chronic 
rheumatic heart disease (RHD). Compared to 79 normal controls (compaction 
ratio=1.4±0.07), patients with VSDs (compaction ratio=2.0±0.2, p<0.0001) and RHD 
(compaction ratio = 2.0±0.3, p< 0.0001) had a marked increase in the compaction 
ratio. A compaction ratio>2 was found in 42% of patients with VSDs and 47% with 
RHD. In VSDs, independent of age and gender, the compaction ratio was positively 
associated with LV mass index (LVMI) (partial r=0.44, p<0.0001), VSD size (partial 
r=0.4, p<0.0001), LV end diastolic diameter indexed (LVEDD) (partial r=0.24, p= 
0.01), and the presence of additional shunts (partial r=0.21, p=0.02). In RHD, 
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independent of age and gender, the compaction ratio was positively 
associated with LVEDD (partial r=0.62, p=0.0001), and LVMI (partial r=0.48, 
p=0.005), and negatively with LV ejection fraction (partial r=0.31, p=0.03).  
The strong association of indices of LV volume load and the compaction ratio 
would suggest that haemodynamic influences are contributing to the compaction ratio 
both in congenital and acquired cardiac disease in childhood. Thus an increased 
compaction ratio may be the consequence of an increased volume preload, and 
therefore may not necessarily occur only as a result of persistence of embryonic 
patterns. 
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PREFACE 
Noncompaction of the myocardium has received increasing attention in the 
medical literature, and has been proposed as a unique cardiomyopathy. Certainly it is 
a strange abnormality where the myocardium is predominantly trabecular, with very 
little compact myocardium. Consequently in its severe form it may have drastic 
clinical implications. However the condition is still poorly understood. The severe 
form is undoubtedly rare, but milder forms of so-called noncompaction are being 
diagnosed with increasing frequency, and there is now a danger of over diagnosis. 
The potential for over diagnosis is partly derived from the diagnostic criteria 
which were proposed rather arbitrarily, based on a small patient cohort, and which 
have been widely accepted and applied. In particular the echocardiographic ratio of 
trabecular to compact myocardium, which we have termed the compaction ratio is 
the only objective diagnostic criterion, and is frequently clinically employed. However 
inconsistencies in the appropriateness of the compaction ratio prompted us to 
consider whether it might be affected by ventricular preload. 
Hence in the following dissertation I have first undertaken a critical review of 
the literature, and the echocardiographic diagnostic criteria. The pathogenesis of 
noncompaction is an intriguing question and possibly the key to understanding the 
difference between true, congenital noncompaction, and a mere increase in 
prominence of the trabeculae. Therefore, in the introduction I have elaborated on 
pathogenesis of noncompaction, and speculated on possible mechanisms of 
noncompaction, trabecular proliferation, and an increased trabecular prominence. 
In the present dissertation I have tested the hypothesis that the compaction 
ratio could be affected by volume preloading. To assess this hypothesis I measured 
ventricular chamber dimensions and mass and the thickness of the compact and 
 xvii 
trabecular layers in both congenital and acquired cardiac disease in 
children leading to increased volume preloads. I subsequently assessed whether 
ventricular chamber dimensions and mass are related to the compaction ratio. The 
methodology for the present study is described in chapter 2 and the results in chapter 
3. Finally I have placed my findings in context with comparisons to other published 
studies in a discussion chapter (chapter 4). 
In support of the present dissertation, the studies described within have been 
presented at the Health Sciences research Day, University of Witwatersrand Faculty 
of health Sciences. August 2006 winning “Best Junior Researcher award, in the 
category of chronic illness and diseases of lifestyle”, and was also presented to the 
South African Heart Association Congress, Cape Town 2006 winning the 2nd prize, in 
the category of Short Presentations. 
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CHAPTER 1 
NONCOMPACTION OF THE VENTRICULAR 
MYOCARDIUM 
A CRITICAL LITERATURE REVIEW AND AIM OF 
STUDY 
 
 
  
 2 
1.1 Introduction and definition of noncompaction 
 
Trabeculae are discrete muscle bundles, covered in endothelium, which are 
found in the apical portions of the left ventricle (LV) in all hearts. Enlarged trabeculae, 
more than 2mm in diameter may occur in 68% of normal hearts, but are virtually 
always three or less in number [1]. In hearts with left ventricular noncompaction 
(LVNC), the lumen contains a prominent network of thin and thick endocardial bands, 
tendons, filaments and trabeculae that intermingle with each other to form a thick 
trabeculated layer, extending from the mid-portion of the LV to its apex [2]. 
Trabeculae are both increased in prominence and excessive in number [3]. The 
outer, compact layer of myocardium tends to be thinner than normal [4, 5, 6]. 
Between the network of trabeculae are deep recesses, in continuity with the 
LV cavity, but not with the epicardial coronary system [3, 7, 8, 9, 10]. In LVNC the 
most commonly affected segments are the apical and mid-ventricular inferior and 
lateral walls [11, 12]. The interventricular septum may be infrequently involved [13, 
14, 15, 16] and the base of the heart is never involved [6]. Examples of LVNC are 
shown in Figures 1.1 a-d. 
In the present dissertation I have studied the factors associated with the 
compaction ratio, a measurement used in the diagnosis of LVNC, in a paediatric 
population with congenital and acquired cardiac disease. Consequently, as an 
introduction to this dissertation, in subsequent sections of the present chapter I will 
critically review the evidence to indicate the anatomical abnormality involved as well 
as the diagnostic criteria, the incidence, the clinical presentation, the clinical 
consequences or implications and the potential pathogenesis of LVNC, highlighting 
the controversies within the field. 
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Figure 1.1a. Left ventricular noncompaction in an infant with complex congenital 
heart disease, isomerism of the left atrial appendages, and a ventricular septal 
defect. From: Freedom, R.M., Yoo, S., Perrin, D., Taylor G., Petersen, S., Anderson, 
R.H. The morphological spectrum of ventricular noncompaction. Cardiol Young 2005; 
15:345-364. Used with permission. 
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Figure 1.1b Left ventricle in a spongiosum heart with situs inversus totalis. “The 
trabeculae carnae of the stratum spongiosum underwent differentiation but failed to 
resorb”. From: Van Praagh, R., Ongley, P.A., Swan, H.J.C. Anatomic Types of Single 
or Common Ventricle in Man. Morphologic and Geometric Aspects of 60 Necropsied 
Cases. Am J Cardiol 1964 13; 367-385. Used with permission. 
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Figure 1.1c. Left ventricle of an infant with noncompaction and a small muscular 
ventricular septal defect, who died of intractable cardiac failure. Used with permission 
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Figure 1.1d. Left ventricle in a patient with tricuspid atresia showing multiple 
trabeculae filling the LV cavity, and probable LVNC. Used with permission 
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1.2 Normal anatomical architecture of the myocardium 
 
As the diagnostic criteria for LVNC depend on an understanding of the normal 
myocardial architecture, I will first review the anatomy of the normal architecture of 
the LV myocardium. The presence of both a trabecular and a compact layer of 
myocardium is not unique to LVNC. Indeed, the healthy myocardium in the LV 
normally has a distinct two-layered appearance with an outer compact layer and an 
inner trabecular layer [1, 17, 18, 19]. As illustrated in Figure 1.2, in the normal LV, the 
trabeculae consist of many fine, muscular structures, covered in endothelium. Small 
recesses can be discerned between the trabeculae, and the trabeculae are mainly 
confined to the apical portion of the chamber, leaving the base and upper third of the 
septum relatively devoid of trabeculae [19]. In addition, in the normal LV, intracavity 
structures such as false tendons, which are composed of muscle and connective 
tissue and which are richly vascularised [20], as well as aberrant bands are common 
[1, 21, 22, 23]. 
The fibre orientation of the trabecular and compact myocardium is complex 
and has been the subject of study for five centuries by prominent scientists such as 
Vesalius, and Harvey. The myocardial body consists of aggregates of cross-
connected myocardial cells in a three dimensional network. Dissection however 
identifies the long axis of these aggregated cells along preferential pathways, looking 
something like a ball of wool [24, 25, 26]. Various models (spirals, helices, and 
geodesics on a nested set of toroidal bodies) of these fibre arrangements have been 
proposed. Nevertheless the fibre architecture of the entire heart remains contentious, 
and it is not within the scope of this dissertation to discuss. However, as it pertains to 
the echocardiographic appearance of the LV, and possibly also to the effect of a 
volume load on the ventricle, I will discuss the myocardial fibre arrangement 
corresponding to the position in the LV where LVNC is normally identified.  
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Figure 1.2a. Normal left ventricular trabeculation in a patient who had a 
perimembranous ventricular septal defect (VSD). The trabeculae are fine muscular 
structures covered in endothelium, and confined mainly to the apex and free wall. 
Small recesses can be seen between trabeculae. 
Septum 
VSD 
Trabeculae 
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Figure 1.2b Cross section of left ventricle below the level of the papillary muscles, 
showing the circumferentially orientated outer compact layer, the oblique inner mural 
trabecular layer, and the longitudinally orientated chamber trabeculae within the LV 
chamber. Picture courtesy of Dr P. King of the Anatomical Pathology Department of 
the University of the Witwatersrand. Used with permission. 
 
 
 
 
Outer compact layer 
Inner oblique layer 
Chamber trabeculae 
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On gross and microscopic examination of a cross section of the LV between 
the base of the papillary muscle and the apex, three discernable layers are found [8, 
9, 24, 26]). Outermost are fibres that spiral circumferentially [24, 25, 26]. Deep to this 
layer are the so- called mural trabeculata, a layer of oblique fibres where the tracks 
crisscross, and where abrupt fibre branchings occur [25]. The bases of the papillary 
muscles attach directly to this layer and not to the outer compact layer [17]. Spaces 
between these mural trabeculae exist, but are seldom apparent at autopsy because 
the heart usually arrests in a contracted state [17]. Within the LV cavity is a network 
of trabeculae (chamber trabeculae) and tendons that lie predominantly longitudinally 
[24, 25]. The fibre orientation of the different layers has important implications when 
discussing the echocardiographic appearance of the myocardium. Furthermore, as 
will subsequently be discussed, in the present study I assessed hearts in which a 
volume load resulted in dilatation of the ventricle. It is therefore of note that due to the 
variations in fibre orientation of the different layers, when stretched, the outer 
compact layer might tend to elongate in a circumferential direction, whilst the inner 
trabecular layers may elongate in longitudinal and oblique directions. Furthermore, it 
has been speculated that dilatation of the LV may reveal recesses between mural 
trabeculae that were not previously apparent [27]. 
 
1.3 The identification of clinical noncompaction:  
History and the development of current approaches 
 
The first clinical description of LVNC was published by Van Praagh in 1964, 
and the same case was more fully described by Feldt et al in 1969 [28, 29]. The 
patient had complex congenital heart disease, congenital heart block and intractable 
heart failure. The morphological LV had multiple, “bizarre, fine trabeculations” which 
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Feldt et al (1969) termed “spongy myocardium” (see figure 1b). These authors (Feldt 
et al 1969) also noted that the spongy myocardium resembled the myocardial pattern 
found in the human embryo at the time of cavitation of the ventricles. Thus it was 
thought that these bizarre trabeculae represented a persistence of the embryonic 
form. 
In 1975 Dusek et al published a report describing an anatomical abnormality 
that appeared to be consistent with LVNC. Unfortunately this led to subsequent 
confusion because in the described cases the myocardial sinusoids in the LV 
communicated with both the ventricular cavity and the coronary vascular bed [30]. 
Persistent intramyocardial sinusoids are a different entity to LVNC, and usually arise 
in cases of severe congenital LV or right ventricular (RV) outflow tract obstruction, 
such as pulmonary atresia with an intact septum [31, 32]. In these patients 
regression of the embryonic sinusoids is impaired during ontogenesis by high luminal 
pressures, resulting in sinusoids communicating with both the ventricular cavity and 
the coronary artery system [33, 34]. Because of the inclusion of cases of sinusoids in 
Dusek’s report, many authors have erroneously linked LVNC to severe left or right 
ventricular outflow tract obstruction [6, 34, 35, 36, 37, 38, 39, 40]. Subsequent to this, 
histology of LVNC has indicated that the deep intertrabecular spaces in LVNC never 
communicate with the epicardial coronary system [3, 9, 27, 36].  
In 1990 Chin et al reported 8 cases of isolated LVNC, diagnosed for the first 
time echocardiographically, and confirmed at necropsy. They proposed an 
echocardiographic ratio of the distance between the epicardial surface and the peak 
of trabeculation, to the distance between epicardium and trough of trabeculation, as a 
way of differentiating a noncompacted myocardium from normally trabeculated 
myocardium [3]. This ratio was somewhat difficult to use in practice, and never 
achieved widespread usage. However, following this report [3] the condition became 
increasingly recognised. 
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In 2001 Jenni et al proposed that isolated LVNC should be classified as a 
distinct cardiomyopathy, and described patho-anatomical, and echocardiographic 
characteristics for its identification [9]. Jenni’s criteria have been widely adopted and 
a plethora of accounts of isolated and non-isolated noncompaction have followed. 
At this stage the World Health Organisation has still to recognize isolated ventricular 
noncompaction as a distinct and separate form of cardiomyopathy. In their 1995 
report it was considered to belong to the group of unclassified cardiomyopathies 
[41]. More recently Maron et al (2006) have suggested that noncompaction be 
grouped with primary cardiomyopathies of the genetic subtype [42]. 
 
1.4 Nomenclature of the anatomical anomaly noted in 
noncompaction 
 
As outlined in the aforementioned discussion, the initial reports termed 
LVNC “spongy myocardium”l [28, 29, 43]. Later, terms such as myocardial 
sinusoids, embryonic myocardium, anomalous ventricular myocardial patterns, 
dysplastic cardiac development, isolated LV abnormal trabeculation, myocardial 
dysgenesis, ventricular dysplasia, and honey-combed ventricle were used [2, 3, 44, 
45, 46]. The terms “noncompaction”, or “non-compaction” are now largely accepted, 
although some authors object to this term because it implies a developmental 
pathogenesis which has not yet been proven [46]. The term “hypertrabeculation” 
has been proposed by Stöllberger et al (2004) and is sometimes used 
interchangeably with “noncompaction” [47]. However these authors (Stöllberger et 
al 2004) define hypertrabeculation as having more than 3 prominent trabeculations, 
a definition that has not gained widespread acceptance [48, 49]. 
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1.5 Identification of noncompaction 
 
Whilst noncompaction may affect both ventricles, the normal architecture of 
the right ventricle (RV) is dominated by a trabecular pattern. This has made the 
condition less apparent in the RV and diagnosis of RV noncompaction is currently 
qualitative [36, 50]. Noncompaction is not thought to affect the atria [51]. Thus criteria 
for the identification of noncompaction of the LV, but not other chambers have been 
developed. Importantly, there are no age-dependent variations in LVNC [46] and 
hence age-specific criteria are not required. Although LVNC has been recognised on 
prenatal echocardiography, where it may be associated with fetal hydrops [52, 53, 
54, 55] the focus has been on developing criteria for post-natal identification. Since 
LVNC is a condition where the trabeculae are both excessive in number and more 
prominent than usual, it may be recognized using various approaches. 
The diagnosis of LVNC may be made at post-mortem on gross inspection 
combined with histopathological techniques [10, 56]. Left ventricular noncompaction 
is being diagnosed more frequently as an incidental finding at autopsy, suggesting 
that in the past its presence has often been overlooked [56]. However, in life, LVNC 
may be recognized using echocardiography, angiography, magnetic resonance 
imaging (MRI) or computed tomography [16, 57, 58, 59] (See figures 1.3a,b,c,d., and 
Figure 1.4). 
Quantitative as well as qualitative diagnostic criteria have been proposed for 
the diagnosis of LVNC using these techniques. However, recognition of LVNC is 
dependent on an awareness of the condition [60]. Echocardiography is considered 
the reference standard for the diagnosis of LVNC in vivo [38, 61]. 
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Figure 1.3a Normal LV myocardium on echocardiogram in short axis view. 
Compaction ratio = 1.4.  
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Figure 1.3b Normal left ventricular myocardium on echocardiogram in subcostal 
view. Compaction ratio, apical = 1.6 
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Figure 1.3c Short axis view of the left ventricle illustrating the thickened layer of 
trabeculae criss-crossing the chamber, in cross section in a patient with 
angiographically confirmed isolated LVNC. Compaction ratio= 5.7 
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Figure 1.3d Subcostal view of the left ventricle showing thickened prominent 
trabecular layer, and a thin outer compact layer, in a patient with LVNC. Compaction 
ratio = 3.4. 
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Figure 1.4  A left ventricular angiogram in a patient with LVNC. Note contrast filling 
of the recesses between trabeculae. 
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1.5.1 Echocardiographic recognition of LV noncompaction, and 
diagnostic criteria 
 
To my knowledge no one has explained the 2-layered appearance of the 
myocardium on echocardiography. From consideration of principles of reflection of 
ultrasound in tissues, it is likely that the trabecular and compact layers of the 
myocardium have a distinctly different appearance because the fibres in the layers 
are differentially orientated (as described in 1.1, above), presenting varying reflective 
properties to the ultrasound beam. The outer, compact layer appears dark, while the 
mural and chamber trabeculae appear to combine as a single continuous layer, 
separate and distinct from the outer compact layer. The mural and chamber 
trabecular layer have multiple reflective surfaces that make them appear light on 
echocardiography.  
The current echocardiographic diagnostic criteria for LVNC are a) excessive 
prominent trabeculations and deep intertrabecular recesses in the LV [9]; b) an LV 
end-systolic ratio of trabecular to compacted layers (compaction ratio) of greater than 
2:1, best visualized in the short axis and usually measured at the position where 
noncompaction is most evident [9] (Figures 1.3 a, b, c and d); c) low scale colour 
Doppler flow into recesses between trabeculae [9]; and d) a predominant segmental 
location in the apical and mid-ventricular areas of both inferior and lateral wall [11, 
61, 62]. An increased number of myocardial segments having a two-layered structure 
might be helpful in differentiating LVNC from normal or other pathologies [11, 19]. 
However, no particular threshold number of myocardial segments has yet been 
proposed as diagnostic. Further, the diagnosis of isolated LVNC requires the 
exclusion of other heart disease [9].  
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In adult patients the characteristic appearance of LVNC has sometimes 
been missed on standard transthoracic echocardiography, but identified on 
transoesophageal echocardiography [63], contrast echocardiography [64] or MRI [14, 
16, 58, 65, 66]. 
In an attempt to clarify the diagnosis of LVNC, and as a step towards defining 
noncompaction as a true cardiomyopathy, Jenni et al (2001) proposed the 
aforementioned echocardiographic criteria, which have been widely accepted, albeit 
with reservations by some authors [13, 44, 67]. Indeed, the general acceptance of 
the compaction ratio as a diagnostic criterion is underscored by the fact that it is used 
to identify non-isolated LVNC, and in addition, the modified ratio has been 
incorporated into the diagnosis of LVNC in pathological specimens, angiography 
images and in MRI studies [19, 56, 68]. However, as these diagnostic criteria have 
been employed in the present dissertation, an appraisal of their utility is important. 
 
1.5.2 The two-layered myocardium and the compaction ratio 
 
In the original publication proposing diagnostic criteria for LVNC, Jenni et al 
[9] state that ”strictly speaking a two-layered structure is found only in isolated 
ventricular noncompaction, and not in left ventricular hypertrophy (LVH) or dilated 
cardiomyopathy (DCM) or any other condition”. Not surprisingly, some investigators 
have therefore interpreted the presence of a two-layered myocardium alone to 
indicate the presence of LVNC [16, 19]. Indeed, Frischknecht et al (2005) suggested 
that hypertrophic cardiomyopathy could be distinguished from noncompaction by the 
absence of a two-layered myocardium in the former [49]. However, as indicated in 
the aforementioned discussion, as the two-layered appearance is the result of 
different orientations of the myocyte fibre bundles, it exists in different proportions in 
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all hearts [69]. Consequently, a threshold of the compaction ratio is essential for the 
diagnosis. 
 
1.5.3 Colour Doppler flow into recesses 
 
Early descriptions of isolated LVNC, frequently indicated that patients who 
would now be considered to have LVNC, had previously been thought to have dilated 
or hypertrophic cardiomyopathy [34, 35, 37, 39, 60, 70, 71]. Jenni et al (2001)[9], in 
defining the aforementioned diagnostic criteria for LVNC, noted that colour flow into 
the recesses between trabeculae helped to differentiate LVNC from other 
pathologies. In hypertrophic cardiomyopathy a thickened two-layered myocardium is 
present, but the deep intertrabecular recesses characteristic of LVNC are typically 
less apparent and there is very limited colour Doppler flow within the myocardium [9, 
34, 38]. However, colour Doppler flow into recesses does not distinguish normal from 
noncompacted myocardium. Normal myocardium includes trabeculation at the apex 
[1, 19] and both normal apical myocardium and noncompacted myocardium will 
demonstrate colour Doppler flow into the recesses between trabeculae. The 
difference between normal and noncompacted myocardium is therefore principally 
determined by the ratio of trabeculated to compacted myocardium. The lack of 
specificity of colour Doppler flow into recesses as a diagnostic criterion is 
underscored by the finding of Frischknecht et al (2005) that in adult patients, 48% 
with DCM, 9% with hypertensive heart disease (HHD), 10% with aortic regurgitation 
(AR), 9% with mitral regurgitation (MR) and 5% with aortic stenosis (AS) had 
perfused recesses [49]. 
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1.5.4 Excessively prominent trabeculations 
 
The presence of excessive, prominent trabeculation and deep recesses 
between the trabeculae is an important diagnostic criterion for LVNC. In other words 
there should be noticeably more trabeculae than normal, and they should occupy 
more of the LV chamber than normal. However this is a subjective criterion. 
Furthermore, up to 3 prominent trabeculations can be found in 68% of normal hearts 
at autopsy [1]. Thus, this criterion may have led to over-diagnosis of LVNC in some 
instances [34]. In reports where LVNC is described as ‘mild noncompaction” [14] or 
“partial penetrance” [72], it is impossible to see how these cases can comply with the 
diagnostic criterion of “excessive prominent trabeculation”.[67] 
 
1.6 Incidence of left ventricular noncompaction 
 
Although initial reports of LVNC suggested that it was very rare  [3, 7, 37], 
with increasing awareness an increased frequency of reports has occurred, 
suggesting that in the past it has been overlooked [39, 65, 73]. Thus the reported 
frequency of identification of isolated noncompaction has changed over time (Table 
1.1). 
The true incidence of LVNC in the general population is unknown because 
usually only symptomatic individuals are referred for echocardiography. However, 
asymptomatic cases of LVNC have been discovered on screening [11, 16, 37, 62, 
72, 74, 75, 76]. Many authors have pointed out that with increasing awareness of the 
condition, and better imaging technologies, the frequency of identification of 
noncompaction is likely to increase [68]. However, ambiguities in the diagnostic 
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criteria make it uncertain whether the condition might now be over-diagnosed [67]. A 
recent study suggests that black individuals may have a higher incidence of 
prominent trabeculations [67].  
 
1.7 Clinical presentation 
 
Although the anatomical substrate of LVNC should be evident at birth, clinical 
presentation can occur at any age [8, 12]. As indicated in Table 1.2, the clinical 
presentation of LVNC is varied. Some have indicated that the symptoms may depend 
on the extent of the noncompacted segments [61], but others have shown weak 
correlations between the extent of LVNC and ventricular dysfunction or symptoms 
[14].  
Initial reports indicated that the prognosis in LVNC was very poor, often 
leading to death or transplantation [3, 5, 7, 8, 34, 36, 37, 63, 70, 77, 78, 79]. 
However, as LVNC is now increasingly recognized, there are numerous reports to 
suggest that noncompaction may have a spectrum of clinical presentations, including 
cases with a much more benign course, and that it may even occur in entirely 
asymptomatic individuals [11, 14, 36, 37, 59, 62, 75, 77, 80]. Asymptomatic cases 
have a significantly better outcome [80].  
The diversity of presenting symptoms and the heterogeneous nature of 
clinical outcomes raises the question of whether LVNC might be an incidental finding 
in some cases. 
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Table 1.1 Reported incidence of left ventricular noncompaction. 
 
Date Author Reference Number 
of LVNC  
Out of Incidence LVNC type/Patient cohort 
1997 Ritter [36] 17 37 555 echos 0.05% Isolated 
2001 Neudorf [7] 7 9000 echos 0.08% Isolated, in children 
2002 Ozkutlu [35] 12 20 341 echos 0.06% Included non-isolated LVNC 
2003 Nugent [81] 29 314 cardiomyopathies 9.2% Isolated, Children 
2003 Pignatelli [76] 36 344 cardiomyopathies 9.5% Children, including non-isolated 
LVNC 
2003 Hughes [68] 31 1535 patients 2.0% Children with CHD 
2004 Ali [13] 15 7250 echos 0.2% Children, with CHD 
2005 Sandhu [82] 6 348 cardiomyopathies 1.7% Community hosp cohort 
2005 Stöllberger [83] 77 28524 echos 0.25% Adults, isolated 
2006 Aras [62] 57 42000 echos 0.14% Adults, Isolated 
2006 Lilje [84] 66 5220 patients 1.26% 38% isolated 
62% non-isolated 
2008 Kohli [67] 47 199 with LV systolic 
impairment 
23.6% Adults, isolated 
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Table 1.2.  References pertaining to reasons for referral/ presenting symptoms reported in the literature. 
 
Symptom/ reason for presentation Adult, isolated LVNC Children, isolated LVNC LVNC+Congenital heart disease 
Heart failure dyspnea, tachypnea, 
orthopnea, 
[8, 34, 36, 57, 62, 64, 66, 74, 
75, 80, 85, 86, 87]  
[3, 5, 7, 15, 35, 37, 60, 70, 
76, 88, 89]  
[13, 29, 53, 54, 90, 91, 92]  
Palpitations  
 
[8, 36, 38, 62, 74, 80, 93]  [37, 70] [91] (adult) 
Syncope, dizziness [8, 35, 36, 40, 58, 62, 71, 80, 
93] 
[16, 35, 37, 70, 76]  
Chest pain  [62, 80]   
Murmurs,  [7, 37, 70, 76] [13, 76]  
CVA/ TIA/ embolic event [6, 62, 75, 85, 94]    
Failure to thrive  [76] i  
ECG /CXR abnormalities  [7, 37, 76] [76] 
Family screening [8, 59, 62, 74, 75, 80]  [3, 37] [13] 
Other screening (e.g. school or Down 
syndrome) 
 [37, 43, 72, 95] [13] 
*Other [8, 36, 74, 94] [3, 15, 76] [35, 76] 
 
* Other includes nausea, fatigue, dysmorphism, congenital heart disease, pneumothorax, cyanosis seizures, cardiac arrest, myocarditis, 
pericarditis, mitral regurgitation and acute abdominal pain. 
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1.7.1 Histopathological findings 
 
In attempting to understand the pathogenesis of the adverse clinical 
outcomes in LVNC, it is important to recognize that histological changes often 
characterise hearts with LVNC. However no specific histological finding is diagnostic 
of LVNC [61]. Within the trabecular zone changes associated with myocardial 
damage, such as interstitial fibrosis, fat cells, ischaemic regions and areas of 
subendocardial replacement fibrosis, necrosis, or scarring [7, 8, 9, 10, 36, 56, 61, 84, 
87, 96] have been reported. In addition, loosely organized myocyte fascicles, 
abnormally thin and angulated myocyte fibres, increased perivascular and interstitial 
spaces, elongated mitochondria, and a reduced number of myofibrils have been 
observed [15, 84]. 
Endocardial fibroelastosis is commonly found [3, 8, 12, 15, 56, 88, 97, 98, 99] 
and poorly defined papillary muscles have been noted [6, 45, 56, 99, 100]. 
Trabecular hypertrophy or coarse trabeculations have been described [15, 54].  
 
1.7.2 Left ventricular systolic dysfunction  
 
Heart failure and systolic dysfunction is the most common clinical 
presentation in patients with isolated and non-isolated LVNC. Estimates of patients 
with heart failure vary from 53- 83%, [12, 36, 62, 76], albeit that LVNC has been 
described in patients with normal LV size and function [44, 65, 70, 72, 75, 101, 102, 
103]. A survey of 238 Italian patients with LVNC indicated that all had a low ejection 
fraction [51]. Furthermore LV systolic dysfunction may progressively deteriorate [8, 
35, 36, 37, 62, 71, 86, 87, 104], or may be undulating, i.e. having periods of recovery 
followed by deterioration [76]. Patients who are initially asymptomatic may later 
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develop LV dysfunction, [37] and the onset of symptoms is commonly delayed until 
adulthood [34, 76].  
The reason for LV dysfunction in LVNC is uncertain. One suggestion is that 
the myocardium in LVNC is morphologically similar to the normal RV trabecular 
pattern. The RV is known to be less able than the LV to maintain systemic circulation 
in the case of univentricular hearts, where it is required to generate systemic 
pressures [3]. It is also possible that pump dysfunction in LVNC is a consequence of 
a reduced effective muscle mass. Indeed, a reduced ventricular pump function in 
cases of LVNC with heart failure could occur secondarily to a reduced thickness of 
the compact layer in relation to the trabeculated myocardium, in regions affected by 
LVNC. [18]. As will be discussed below (1.6.1) this would be consistent with 
observations from invertebrate hearts where a highly trabeculated myocardium is an 
adaptation for circulating large blood volumes, but does not generate high pressures. 
In animals with very active lifestyles, or those with large bodies, requiring high 
pressure pump function, the compact myocardium is well developed.  
A number of histological changes have also been described in LVNC and 
these may promote a reduced contractile function (see above). With respect to tissue 
ischaemia, coronary angiography in LVNC usually demonstrates normal coronary 
vessels [4, 34, 87, 105], although in some cases coexisting major coronary artery 
disease is present [47, 57, 82]. Left ventricular dysfunction may nevertheless be the 
result of relative ischaemia due to mismatch of myocardial oxygen supply and 
demand [5, 34], or micro-coronary dysfunction as evidenced by restricted myocardial 
perfusion and a decreased flow reserve in areas of ventricular noncompaction in 
children [77]. 
Alternatively, LVNC might not cause LV dysfunction, but may merely be a 
marker for an underlying cardiac pathology. Indeed, a normal wall motion is more 
common in noncompacted than in compacted segments [106], and symptoms 
correlate with systolic dysfunction, but not compaction ratio or the number of 
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segments involved [80]. Thus, whether LVNC is the cause of LV systolic dysfunction, 
or is merely a marker for underlying pathology is still uncertain. 
  
1.7.3 Left ventricular diastolic dysfunction 
 
Diastolic dysfunction as manifest by a restrictive filling pattern on echo 
Doppler or high end-diastolic pressures at catheterization may occur with LVNC [8, 
12, 14, 34, 37, 52, 59, 76, 78, 100, 105, 106, 107, 108]. The tei index (a measure of 
both systolic and diastolic dysfunction) is abnormal, although not predictive of poor 
outcome [12]. Pulmonary hypertension as a consequence of restrictive physiology 
and raised LV diastolic pressures has also been noted at cardiac catheterization or 
during echocardiography [7, 34, 37, 108]. Diastolic dysfunction in LVNC is thought to 
result from a combination of abnormal ventricular relaxation and restriction to filling 
caused by the abundance of intracavity trabeculae [34, 37]. Endocardial 
fibroelastosis is frequently reported [15, 37, 56, 85, 88, 98, 107, 109] and may also 
play a role in causing a restrictive physiology in LVNC. 
 
1.7.4 Left ventricular dilatation 
 
Left ventricular dilatation may occur in isolated and non-isolated LVNC [3, 5, 
8, 16, 63, 75]. LVNC can however occur in patients with normal LV cavity dimensions 
[78, 80, 102, 108, 110]. A larger LV cavity in LVNC may indicate a poorer prognosis. 
Indeed, left ventricular end-diastolic diameter (LVEDD) at the time of initial 
presentation of LVNC is significantly larger in non-survivors as compared to survivors 
[8], and a poor outcome in LVNC may be predicted by an increased compaction ratio, 
and/or LVEDD at initial presentation [12]. The association between LVNC and 
increased LV cavity dimensions is usually attributed to the presence of LVNC leading 
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to LV systolic and diastolic dysfunction. However, as will be discussed, LV dilatation 
may accentuate trabeculations and in turn promote an LVNC-like appearance [21, 
23, 111]. Thus, again, whether LVNC is a cause of or a marker for LV dilatation has 
not been established. 
 
1.7.5 Thromboembolism in LVNC 
 
In LVNC, thrombus formation between trabeculae has been detected both 
histologically in explanted hearts [3] or echocardiographically [3, 37, 62, 64, 76, 77]. 
Moreover, thromboembolic events have been reported to occur in patients with LVNC 
[6, 8, 36, 75, 85, 94]. Presumably the mechanism of the thrombus formation in LVNC 
is through stasis of blood within the trabecular recesses. However, thrombi almost 
invariably occur in patients with underlying LV systolic dysfunction or atrial fibrillation, 
a known risk factor. No thromboembolic events were recorded in untreated patients 
with an LV ejection fraction greater than 30% [80]. Thus it is not certain whether the 
presence of deep intramyocardial recesses is an independent risk factor for thrombus 
formation. 
 
1.7.6 Arrhythmias and other electrocardiographic abnormalities in 
LVNC 
 
A high prevalence (up to 75% of a cohort of 36 children [76]) of diverse 
electrocardiographic (ECG) abnormalities has been reported to occur in LVNC. 
These include ventricular hypertrophy [62, 76, 78, 91, 107], which may have extreme 
QRS voltages similar to those noted in Pompe’s disease. In addition, isolated or 
diffuse T-wave inversion [37, 70], Wolff-Parkinson-White syndrome [3, 35, 37, 58, 60, 
65, 76], first degree heart block [71], bundle branch block [8, 34, 35, 58, 60, 62, 64, 
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88, 103], complete heart block [3, 35, 37, 40, 62, 87, 99, 100, 112, 113, 114], sick 
sinus syndrome [103, 115], bradycardia [34, 37, 54, 103], atrial fibrillation [8, 34, 36, 
37, 40, 62, 78, 80], atrial and ventricular premature contractions, and tachycardias [8, 
35, 38, 71, 76, 80, 85] and ventricular fibrillation [3, 8, 29, 34, 36, 37, 52, 60, 71, 76, 
85, 87] have been reported to occur in LVNC. In 3 reported series of patients with 
LVNC, sudden cardiac death accounted for 6/34 [8] , 3/17 [36], and 5/65 [80] deaths. 
In contrast however, not all studies have demonstrated a predisposition to 
arrhythmias in LVNC. Indeed, in a survey of 238 patients with LVNC in Italy, only 9 
had supraventricular tachyarrhythmias, all atrial fibrillation [51]. 
The pathogenesis of arrhythmias in LVNC is unclear. Scarring and fibrosis 
may predispose to arrhythmias [36]. Normal ventricular conduction at 6 weeks, but 
bundle branch block at 4 months in one patient suggested that delayed ventricular 
conduction might be due to the development of severe endocardial fibroelastosis 
[88]. Wolff-Parkinson–White syndrome in the presence of LVNC may be explained by 
sharing a similar pathogenesis. Wolff-Parkinson–White syndrome is thought to arise 
from failed regression of developmental embryonic atrioventricular muscular 
continuity, and it is therefore not inconceivable that it may occur where there has 
been a failure of myocardial compaction [60].  
 
1.7.7 Prognostic indicators in LVNC 
 
Factors found to contribute to a poorer outcome (transplantation or death) in 
LVNC include: adults who have heart failure, sustained ventricular tachycardia or an 
enlarged left atrium [80], presentation of LVNC during childhood [116], the presence 
of additional congenital heart disease [117], a reduced LV ejection fraction at the 
initial presentation and New York Heart Association (NYHA) functional capacity [62], 
and both a compaction ratio greater than 3 and an LVEDD >5cm [12]. 
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1.8 Pathogenesis of noncompaction 
 
1.8.1 Noncompaction as an evolutionary adaptation 
 
In animals noncompaction may represent an evolutionary adaptation related 
to environment. Indeed, in cold-blooded animals, the cardiac musculature may be 
almost entirely trabecular or spongy, resembling noncompaction [2, 30, 44]. The 
blood supply to the myocardium in these cases is mostly by diffusion through the 
recesses, as there is no well organized epicardial coronary system. This form of 
myoarchitecture is advantageous, and indeed necessary for circulatory function in 
many fish, despite its presence being considered to be disadvantageous in humans 
[2, 118]. 
Studies in bony fish indicate that there is a relationship between activity 
patterns (sedentary or active), myoarchitecture, and the pattern of blood supply to the 
hearts ventricle. Sedentary fish hearts have a predominantly trabecular myocardium, 
which is perfused through venous channels, have a high mitochondrial density in the 
cardiomyocytes, and function as low pressure pumps [119]. An example of this is the 
icefish, Chaenocephalus aceratus, which lives in Antarctic waters. It is adapted to an 
environment of stable low temperature and high oxygen content. The ice fish was 
once termed the “bloodless fish” because its blood is nearly devoid of haemoglobin 
and red blood cells. It compensates for this by having a high blood volume (2-4 times 
higher than most teleosts) [118], ensuring that an adequate amount of oxygen is 
carried in the dissolved rather than haemoglobin bound form [118]. Its heart, which 
as indicated consists of a predominantly trabecular myocardium, has a relatively 
increased weight for body weight, has high ventricular compliance, and works against 
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a low systemic impedance [2, 118, 119]. There is a high ratio of surface area to 
cavity volume, assisting in diffusion [118]. Multiple recesses result in an effectively 
multi-chamber ventricle, and although it handles a relatively large volume, the wall 
stress is low [118]. It functions as a specialized volume pump moving large stroke 
volumes at a low heart rate, but it is not able to generate high pressures [118].  
In contrast, active fish such as adult tuna Thunnus thynnus, have a well 
developed dense, compact myocardium and arterial coronary supply. The heart of 
the adult tuna acts as a high pressure pump and is thus able to meet high metabolic 
demands [120]. 
In mammals too, noncompaction of the myocardium may represent an 
adaptive change. Indeed, in vertebrates, the relative amount of compact myocardium 
is related to the heart mass, i.e. in larger animals who need to generate a greater 
stroke volume, the compact layer is better developed [121]. 
 
1.8.2 Embryonic morphogenesis of the myocardium 
 
In humans LVNC has generally been thought to occur as a consequence of 
an abnormal persistence of the highly trabeculated myocardium that occurs during 
cardiogenesis [2, 3, 29]. Prior to discussing this theory therefore, a description of 
changes in the myocardium during cardiogenesis is of importance. 
Early in cardiac development, at the end of the 4th week of gestation, the 
heart has a very thin outer compact later and multiple trabeculae within the LV 
chamber [2] (Figure 1.5). The resulting increase in surface area probably facilitates 
myocardial blood supply by exchange perfusion. It is likely that during this 
developmental period the trabeculae generate much of the contractile force of the 
heart [18, 122]. The trabeculae also have unique viscoelastic properties, and are 
associated with the terminal branches of the conduction system, thus providing the 
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morphological substrate for coordinated contraction [122, 123]. Epicardial coronary 
growth during the second month is associated with the disappearance of “sinusoids” 
and the transformation of some of the spongy myocardium into a compact 
musculature [56]. The developing myocardium gradually condenses, and the large 
spaces within the trabecular network disappear. 
Papillary muscles and chordae tendinae develop from compaction 
(coalescence) of the trabecular layer [124] (Figures 1.5 a, b). The chordae which are 
initially composed of myocardial cells, are replaced with fibrous tissue [124]. Thus 
compaction of the myocardium and formation of the papillary muscles are closely 
linked processes. Papillary muscle abnormalities have been reported in cases of 
LVNC [6, 45, 56, 99, 100].  
Compaction progresses from the epicardium towards the endocardium, and 
from the base towards the apex [84]. Trabecular compaction is usually more 
complete in the left side than in the right side of the heart [3, 33]. 
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Figures 1.5 a and b. Sections of human embryo heart at Carnegie stage 16 (a), and 
18 (b), showing an extensive trabecular layer, thicker than the compact layer. The 
trabecular layer becomes compacted to form the papillary muscle (asterisks). From: 
Freedom, R.M., Yoo, S., Perrin, D., Taylor G., Petersen, S., Anderson, R.H. The 
morphological spectrum of ventricular noncompaction. Cardiol Young 2005; 15:345-
364. Used with permission. 
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1.8.3 Persistence of embryological patterns 
 
The most widely held view of the pathogenesis of LVNC is that it is a 
congenital cardiomyopathy, and occurs as a persistence of the embryological pattern 
of trabeculae found at the time of cavitation of the ventricles [2, 29]. This theory 
implies that LVNC should be present at birth but that clinical manifestations may be 
delayed until later in life [9, 37, 60, 70, 75]. Evidence that supports this hypothesis 
includes the fact that there is a similarity in appearance of the embryonic pattern and 
the postnatal appearance of the noncompacted heart; that genetic interruptions of 
that process in the fish, chick, mouse and possibly humans results in persistence of 
the embryonic pattern, resembling LVNC; that LVNC appears to have a hereditary 
basis (familial and genetic associations - see below); and that LVNC is often 
associated with other congenital heart disease [2]. 
 
1.8.4 Genetics of LVNC 
 
The prevailing hypothesis for the mechanism of isolated LVNC is that a 
genetic defect occurs that results in persistence of the embryonic trabeculated 
myocardium. Indeed, LVNC aggregates in families [3, 6, 8, 13, 14, 15, 36, 38, 52, 72, 
74, 75, 76, 85, 97, 125]. The search for a genetic marker for LVNC in humans, has 
revealed genetic heterogeneity [97, 126, 127, 128]. A growing list of mutations have 
been associated with LVNC, including mutations of the G4.5 (taffazin) gene located 
on Xq28 (Barth syndrome) [15, 116, 129], the -dystrobrevin gene [97], the DTNA 
gene [126], the Cypher/ZASP gene [130], the lamin A/C gene [131], at 11p15 [132], 
and 22q11[76] or in other positions [128]. 
Importantly, the clinical phenotype within families as well as unrelated 
individuals with the same mutation is highly variable [126]. Indeed, even in familial 
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cases, LVNC demonstrates a wide phenotypic spectrum that ranges from extreme 
severity such as prenatal/neonatal lethality to mild forms of noncompaction (not 
meeting diagnostic criteria) with a complete lack of symptoms [14]. Furthermore, in 
familial cases, relatives may have features consistent with dilated cardiomyopathy, 
hypertrophic cardiomyopathy or restrictive cardiomyopathy rather than LVNC [37, 
75]. Mutations of the G4.5 gene can result in a variety of cardiac phenotypes, 
including a dilated cardiomyopathy, endomyocardial fibroelastosis, and a dilated 
hypertrophic cardiomyopathy [97]. Furthermore these phenotypes have been 
reported to change over time, possibly in response to therapy [97]. Understanding 
the genetics of LVNC therefore may depend on clarifying the distinctive diagnostic 
features and investigating the contribution of all known cardiomyopathy-causing 
genes with overlapping morphology [128]. 
In support of a genetic contribution nevertheless, LVNC is also known to be 
part of various syndromes including Barth, Noonan, Roifman, Melnick-Needles, Nail-
Patella, Toriello-Cary, and others [2, 99, 112, 129, 133]. Dysmorphism is occasionally 
present [3, 37, 74, 76, 80, 85, 103]. However, the majority of these are single case 
reports and systematic studies are lacking. Therefore, it is uncertain whether these 
syndromes are always associated with LVNC or whether it is just an incidental finding 
in some. 
 
1.8.5 Experimental noncompaction supports a genetic mechanism 
 
Left ventricular noncompaction has been experimentally linked to various 
genetic mutations, thus supporting the likelihood that LVNC is a congenital 
malformation and has a hereditary basis. Experimentally, LVNC has been shown to 
result from disruptions in several genetic pathways. Genetic and molecular studies 
have shown that Bone Morphogenetic Protein 10 (BMP 10) is essential for 
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maintaining cardiac growth during murine cardiogenesis. If BMP10 is upregulated in 
hearts deficient in FKBP12, lethal LVNC results [134]. In mice, a deficiency of 
Jumonji, a nuclear protein necessary for normal heart development, results in 
ventricular septal defects (VSDs), a double outlet right ventricle, and LVNC [135]. 
King et al have studied the expression of Peg 1, a gene of unknown function, but 
which is widely expressed in the mouse embryo [135]. Mice lacking the Peg1 gene 
are viable, but have intrauterine growth retardation, and develop a subtle alteration in 
the pattern of myocardial trabeculation similar to that seen in human LVNC [136]. 
Shou et al (1998) found that mice lacking the FKBP12 gene have VSDs and dilated 
hearts in which the trabecular pattern mimics LVNC [137]. 
 
1.8.6 Noncompaction as an acquired disorder 
 
As indicated in the aforementioned discussion, if LVNC is a congenital 
malformation, then it should be present in the prenatal and early postnatal period. 
However, various findings do not fit the congenital cardiomyopathy theory, and 
questions have been raised as to whether LVNC could be acquired postnatally. 
Firstly, despite a normal prenatal or early postnatal echocardiograph noted in some 
infants, these same infants may develop LVNC only later in life [15, 35, 115]. This 
nevertheless could be attributed to limitations in early imaging [15, 78, 138]. 
Secondly, a compaction ratio of >2:1 can be found in both congenital and acquired 
cardiac pathology and this will be described in subsequent sections. Although the 
presence of LVNC together with other congenital heart disease may not be 
surprising, the presence of LVNC in acquired pathology raises the question as to 
whether LVNC is indeed only a congenital abnormality. Thirdly, further suggestive 
evidence from case series favours a non-congenital mechanism of LVNC. Indeed, 
the ratio does not appear to be consistent in time [13, 44]. Ali and Godman (2004) 
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have described a case where ventricular dimensions changed and function improved 
and that these changes were associated with a reduction of the compaction ratio 
from 2.2 to 0.9 [13]. Moreover, Stöllberger and Finsterer reported on a case of 
disappearance of noncompaction [111]. Pignatelli et al (2003) described two cases 
that they termed the “undulating phenotype” in which the compaction ratio changed 
over time [76]. Further, Toyono et al reported on a patient who had regression in the 
degree of LVNC in response to treatment with carvedilol [89]. Pfammatter (1995) 
described a patient with myocarditis due to Coxiella infection who developed a 
dilated LV with a spongy appearance and the spongy appearance normalized 
following treatment and reductions in cavity volume [139]. In addition, several cases 
of acquired LVNC, or increased compaction ratio following deterioration in LV 
function have been reported [140, 141, 142, 143]. Furthermore, our group have 
documented a number of cases where the compaction ratio has changed, following 
medical or surgical interventions. See Table 1.3, and Figure 1.6a, b.  
If LVNC was entirely attributable to a congenital persistence of trabeculae, the 
compaction ratio should remain constant throughout life. Temporal changes in the 
compaction ratio related to the LV function or size suggest that perturbations in the 
volume status of the ventricle, or other influences, may affect the prominence of the 
trabeculae, mimicking LVNC. Whether these changes are simply due to increased 
prominence of existing trabeculae, or whether trabecular proliferation might occur in 
as a compensatory response to unfavourable haemodynamic conditions, will be 
discussed. 
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Table 1.3. Examples of our own cases where the compaction ratio has improved over time, following interventions. 
Patient  Background Date 1 LVEDD1 
(mm) 
EF1 
(%) 
CR1 Date 2 LVEDD2 
(mm) 
EF2 
(%) 
CR2 
1* Cardiac failure, DCMO  30/08/2004 49 12 3.0* 28/06/2007 37 70 1.5* 
2 HIV+, DCMO  6/01/2005 55 25 4.4 11/10/2006 45 53 2.0 
3 VSD, and AR for 
surgical closure/repair  
22/10/2007 63 8 4.5 02/11/2007 
(post operative) 
49 48 2.6 
4 RHD, MR and mild AR 23/11/2007 54 60 3.1 07/12/2007 46 48 2.7 
5 HIV+, DCMO, PTB  16/09/2004 53 46 3.6 11/07/2007 53 58 1.1 
6 Large VSD for repair 19/07/2005 37 79 2.5 26/03/2008 
(post operative) 
30 66 1.4 
7 RHD, severe MR, mild 
AR  
20/04/2006 65 68 2.4 27/03/2008 
Post MV replacement, 
residual mild MR/AR 
48 63 1.4 
8 RHD severe MR, mild 
AR  
07/02/07 77 58 3.3 10/05/07 MV replacement, 
mild AR 
57 40 1.9 
9 Large inlet VSD  14/03/2007 45.5 77 2.6 Post VSD closure, with 
small residual VSD, and 
32.5 84 1.8 
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small residual VSD, and 
moderate LV to RA shunt 
10  Myocarditis  18/07/08 42.9 45 3.2 25/07/08 Post polygam 
therapy 
37.8 66 1.5 
11 Multiple VSDs, including 
large muscular VSD  
19/08/2004 30.8, 
LVED/BSA0.5 
48.7 
76 3.0 7/08/2008, Post amplatzer 
closure of large VSD, 
residual small VSDs  
36  
LVED/BSA0.5 
43.8 
59 2.2 
12 Congenital mitral 
regurgitation  
13/02/08 39 74 2.1 07/08/2008, Post operative 
mitral valve replacement 
33 66 1.5 
 
CR, compaction ratio; EF, ejection fraction; LVEDD, LV end diastolic diameter; AR: aortic regurgitation, DCMO: dilated cardiomyopathy, PTB, 
pulmonary tuberculosis, HIV+ human immunodeficiency virus.  
* Illustrated case see Figure 1.6
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Figure 1.6 Two echocardiograms taken 22 months apart, of the same patient diagnosed with a dilated cardiomyopathy,  
Figure 1.6a First echocardiogram, 30/08/2004. Dilated LV, LVEDD 49mm, compaction ratio -3. 
Figure 1.6b Repeat echocardiogram, 28/06/2007. Improved LV size and function following medical treatment. LVEDD 37mm, compaction 
ratio -1.5 
These Echocardiograms were taken 4 years apart, on the same patient. In each case the same echocardiographic views were employed. 
Care was taken in each case to identify the cross section of the ventricle with the most circular shape, between the bases of the papillary 
muscles and the apex of the heart, and therefore they are comparable views. 
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1.8.7 Trabecular proliferation as a compensatory response in some 
cardiac disease 
 
Consistent with the view that in certain species excessive trabeculae may have 
a beneficial effect (see section 1.5.1 above), Finsterer, Stöllberger and Blazek (2006) 
have proposed that LVNC may be a compensatory change in some cardiac 
pathologies [144]. They propose in this regard that an increase in size or quantity of 
trabeculae could increase the mass and surface area of the LV and hence may 
improve stroke volume. Further, LVNC may increase the endocardial surface area 
and hence potentially improve oxygenation via the endocardium [144]. It may assist 
the impaired myocardium, resisting dilatation by tightening the myocardial structure 
[144]. It may increase the muscle mass at the apex, the segment of the LV with the 
highest ejection fraction; and it may enhance viscoelastic properties [123] which 
might improve ventricular performance in the face of a haemodynamic challenge. 
A number of mechanisms may explain trabecular proliferation in a setting of 
cardiac disease. Generally the adult heart responds to adverse haemodynamics only 
by cellular hypertrophy and dilatation [145]. However, in neonates and children up to 
the age of 6 years, gap junctions and fascia adherens junctions, which are distributed 
over the entire cell surface [146], may facilitate remodelling of the myocardium. 
Indeed, in chick embryos, experimental changes in loading conditions have been 
shown to lead to changes in ventricular myoarchitecture. Increased pressure loading 
leads to an accelerated development of the compact layer (increased number of cell 
layers) and thicker, coarser trabeculae, with diminished intertrabecular spaces in the 
LV [145]. In contrast, volume loading of the RV results in an increased number of 
trabeculae, which are thinner than normal [145]. Thus in the chick embryo trabecular 
proliferation may occur in response to adverse haemodynamic conditions. It is not 
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known if this effect applies in humans and could continue postnatally and into adult 
life. 
Against the theory that acquired noncompaction is due to trabecular 
proliferation is the finding that the compaction ratio regresses when LV 
haemodynamics improve. While an increase in trabeculae in response to adverse 
haemodynamics has been shown to occur experimentally, a regression would require 
resorption or loss of trabeculae by some unknown mechanism, and seems less likely. 
 
1.8.8 Acquired noncompaction due to increased prominence of 
trabeculae 
 
A possible explanation for LVNC in identifiable cardiac pathologies, that does 
not necessarily negate the other abovementioned notions of the pathogenesis of 
LVNC has been proposed [111]. Unequivocal, LVNC as seen in figure 1 is a 
pathological condition and may well be due to persistence of the embryonic pattern. 
Furthermore, it is not known whether trabecular proliferation may occur as an 
adaptation to adverse haemodynamic conditions. However, LVNC is defined as a 
condition in which there are both an increase in the number of trabeculae and the 
prominence of the trabeculae in the LV. Echocardiographically it not possible to 
distinguish whether a thickened trabecular layer is a result of an increase in number 
of trabeculae or the prominence of trabeculae, or both. It is therefore possible that an 
increase in the prominence of the trabecular layer may give the appearance of 
LVNC, but it is a consequence of stretching and thickening of the trabeculae in an 
overfilled ventricle [111]. An increased prominence of LV bands and trabeculae 
(including measurement of the compaction ratio), has been previously noted in 
patients who had LV dilatation, hypertrophy and systolic dysfunction [21, 23, 67, 
106]. 
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It is recognized that both dilatation and hypertrophy result from a chronic 
increase in LV preload. In an overfilled ventricle the interlaced trabeculae act as 
struts or buttresses, and the spaces between the trabeculae may become enlarged 
and deeper. Hitherto undetected recesses within the mural trabecular layer might 
also be revealed. Hence as the ventricle dilates the trabecular layer appears to 
become thicker. In addition if the individual trabeculae were hypertrophied, they 
would appear more prominent, and the thickness of the trabecular layer would be 
increased. The outer compact layer of myocardium composed of circumferentially 
orientated fibres might become stretched and thinner. Echocardiographically the 
overall result of these would be an increase in the compaction ratio. This is an 
apparent LVNC, and may be indistinguishable echocardiographically, by current 
diagnostic criteria from true LVNC (See Figure 1.7 a, b). Importantly, if this were true, 
the prominence of the trabecular layer could vary under differing haemodynamic 
conditions. This would distinguish it from LVNC due to excessive numbers of 
trabeculae, where the compaction ratio would be fixed. 
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Figure 1.7 Short axis echocardiogram of the left ventricle in patient with rheumatic 
heart disease and a severely dilated left ventricle showing prominent trabeculae and 
an increased compaction ratio. Compaction ratio =4.5 
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Figure 1.8 Short axis view of a dilated left ventricle in a patient with repaired sub 
mitral aneurysm, with residual left ventricular dysfunction. Compaction ratio= 3.4. 
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1.9 Association of LVNC with congenital, acquired and 
valvular heart disease and the clinical implications 
thereof  
 
1.9.1 Ventricular septal defects and LVNC  
 
Left ventricular noncompaction is frequently noted in other forms of congenital 
heart disease. Ventricular septal defects are one of the most common congenital 
heart abnormalities noted in association with LVNC, appearing in 14/26 (53%) of a 
survey of reports concerning LVNC and congenital heart disease (Table 1.4). 
Muscular VSDs may comprise 90% of the total VSD number noted to occur in 
association with LVNC [84]. Some reports of so-called isolated noncompaction, on 
closer analysis include patients with congenital heart lesions such as small VSDs that 
were dismissed as haemodynamically inconsequential [12, 14]. This association with 
VSDs may be coincidental because VSDs are one of the commonest congenital 
heart lesions accounting for approximately 20% of all congenital heart pathologies. 
However, there may be a developmental association of VSD and LVNC (See 1.5.5 
above describing genetic mutations resulting in both LVNC and VSDs). In this regard 
it is also of interest to note that in the chick embryo the formation of the 
interventricular septum has been shown to be the result of coalescence of trabecular 
sheets[147]. Thus, the formation of the muscular interventricular septum and the 
compaction of the myocardium may be closely linked processes. Residual small 
muscular VSDs have been proposed to result from incomplete or abnormal 
coalescence of embryonic trabecular sheets [147].  
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Table 1.4. Summary of reports in the literature where LVNC is described with congenital heart diseases. 
No. Author Reference Date Type of congenital heart disease 
1 Feldt [29] 1969 Dextrocardia, transposition great vessels, muscular VSDs, pulmonary stenosis 
2 Dusek [30] 1975 Aortic stenosis, fibroma, anomalous left coronary, pulmonary atresia 
3  Allenby  [45] 1988 Muscular VSD, Anomalous RV muscle bands, anomalous papillary muscles 
4 Ichida [37] 1999 VSD(6 cases), PDA, hypoplastic LV, ASD 
5 Kamei [91] 2001 Double orifice mitral valve 
6 Dagdeviren [113] 2002 Atrial septal aneurysm, cleft mitral valve 
7 Ozkutlu [35] 2002 Heterotaxy, complex hearts, anomalous pulmonary venous drainage, multiple VSDs, 
coarctation of aorta 
8 Pignatelli [76] 2003 VSDs (3 cases), hypoplastic RV+pulmonary stenosis(1), Hypoplastic LV(1) 
9 Cavusoglu [104] 2003 2 cases bicuspid aortic valve 
10 Ali [13, 101, 148] 2002/4 VSDs, including muscular VSDs, mitral valve abnormalities 
11 Wald  [12, 149] 2004 ASD2, 2 small muscular VSDs, 2 cases mild Ebstein’s anomaly 
12 Gorgulu  [150] 2004 Double orifice mitral valve  
13 Attenhofer [151] 2004 3 Cases Ebstein’s anomaly 
14 Friedberg [54] 2005 Left Atrial isomerism, complex hearts 
15 Freedom  [2] 2005 Left atrial isomerism with VSD 
16  Sandu  [82] 2005 VSD, bicuspid aortic valve 
17 Dogan [114] 2005 Congenitally corrected transposition 
18  Burke [56] 2005 4 cases VSD; partial anomalous pulmonary venous return, mitral abnormality, pulmonary and 
tricuspid valve dysplasia, right coronary stenosis 
19 Alehan  [50] 2005 Atrioventricular septal defects, hypoplastic LV, transposition of great arteries, pulmonary atresia 
20 Lilje [84] 2006 VSDs, LV and RV outflow obstruction, Ebstein’s anomaly, tetralogy of Fallot, pulmonary atresia 
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with intact septum. 
21 Sugiyama [100] 2006 Double orifice mitral valve with mitral regurgitation (2 cases) 
22 Johnson  [14] 2006 VSDs 
23 Tatu-Chitoiu [92] 2006 VSD, coarctation of aorta 
24 Hughes [68, 117] 2007 Single ventricle, VSDs, conotruncal abnormalities 
25 Unlu [152] 2007 VSD, bicuspid aortic valve, ruptured sinus of valsalva 
26 Bottio [90] 2007 Pulmonary stenosis, severe mitral incompetence 
VSD, ventricular septal defect; PDA, patent ductus arteriosus; ASD, atrial septal defect; RV, right ventricle; LV left ventricle 
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1.9.2 Clinical implications of LVNC in congenital heart disease 
 
When LVNC is found in association with congenital heart disease, most 
commonly VSDs and right ventricular hypoplasias, these children have a significantly 
poorer outcome due to sudden death, or transplantation, or progressive LV 
dysfunction, than those with equivalent congenital heart lesions who did not have 
LVNC [68]. An interesting observation, prior to the current widespread awareness of 
noncompaction, was made in 1989, where Seliem et al showed that “inappropriate 
LV hypertrophy” (possibly noncompaction) in patients with tricuspid atresia was 
related to a poorer outcome after the Fontan procedure [153] (See figure 1.1d as an 
example of tricuspid atresia with probable LVNC). One possible explanation for the 
poor outcome in children with congenital heart disease and LVNC as compared to 
those without LVNC is that presence of an intrinsically abnormal myocardium may 
further impair myocardial performance among patients with underlying 
haemodynamic problems caused by congenital heart disease [54]. However, Ali et al 
have documented a patient with LVNC and VSDs, in whom cardiac failure and 
dilatation of the left sided chambers improved with spontaneous closure of the VSDs 
[13]. This would seem to indicate that the contribution of LVNC to cardiac dysfunction 
in VSDs is minor at best. Further work is therefore still required to establish the 
interpretation of the relationship between LVNC and poor outcomes in patients with 
congenital heart lesions. One hypothesis is that increased trabecular prominence in 
congenital heart disease could be associated with increases in cavity dimensions, 
and hence that the relationship between LVNC and poor outcomes in patients with 
congenital heart lesions is simply an index of the size of the shunt and the magnitude 
of the preload on the LV. 
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1.9.3 Valvular disease and LVNC 
 
There is evidence to indicate that the presence of LVNC is associated with 
both congenital and acquired disease of the cardiac valves [56]. Organic mitral valve 
disease, including leaflet and chordal thickening, restricted movement, mal-
coaptation, mitral regurgitation (ranging from mild to severe), abnormal chordal 
attachments, and abnormal papillary muscles have been described to occur in 
association with LVNC [45, 56, 99, 101]. Double orifice mitral valve is usually a very 
rare anomaly, yet four cases associated with LVNC have been described [91, 100, 
150]. In addition congenital mitral stenosis and cleft mitral valve have been reported 
with LVNC [113]. Further, there are descriptions of LVNC occurring in cases of 
acquired mitral valve disease, i.e. rheumatic mitral stenosis and regurgitation [27, 
108, 154, 155]. Approximately 5% of patients with mitral regurgitation may have a 
compaction ratio >2 [49]. In addition many reports describe dilated ventricles with 
functional mitral regurgitation [34, 59, 71, 80, 86, 90, 105]. It is probable that the 
relationship in these circumstances is the consequence of the well described 
association between mitral regurgitation and cavity dimensions.  
With respect to other cardiac valves, congenital critical aortic stenosis [2], 
and calcific aortic stenosis in a tri-leaflet aortic valve, including considerable aortic 
and mitral regurgitation has been reported [105]. Up to 5% of patients with aortic 
stenosis may have a compaction ratio >2 [49] Further, an association of Ebstein’s 
anomaly of the tricuspid valve and LVNC has also been described [151]. 
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1.9.4 Dilated cardiomyopathy and LVNC 
 
In a cohort of children with cardiomyopathies, up to 10% have been found to 
have LVNC [76, 81]. Approximately 26% of patients with dilated cardiomyopathy may 
have a compaction ratio>2 [49]. However differentiation of LVNC from dilated 
cardiomyopathy remains contentious. Whilst some authors have confidently assigned 
study patients into subgroups of dilated cardiomyopathy and LVNC on the basis of:  
thicker basal interventricular and posterior walls, and better LV function in LVNC 
[105], less prominent trabeculations [38], or a greater LVEDD (in dilated 
cardiomyopathy) [49], others have suggested that the difference between dilated 
cardiomyopathy and LVNC is so ill-defined that transitional variants between dilated 
cardiomyopathy and LVNC may exist [36], or that LVNC should be classified as a 
subtype of dilated cardiomyopathy [75]. 
Importantly, when comparing LVNC and dilated cardiomyopathy with 
comparable degrees of spherical remodelling and dysfunction, tissue Doppler 
parameters indicated no difference between the two groups [156]. Moreover, ECG 
criteria (bundle branch block, atrio-ventricular block, or electrocardiographic signs of 
LV hypertrophy) were not helpful in discriminating between LVNC, hypertrophy due 
to hypertensive or valvular disease, and dilated cardiomyopathies [49]. 
 Ambiguity in diagnostic criteria, and failure to appreciate that an increased 
prominence of trabeculae could result from dilatation of the ventricle, may account for 
these discrepancies. 
 
1.9.5 Other cardiac or non-cardiac conditions and LVNC 
  
Left ventricular noncompaction has been reported to occur with other 
acquired heart diseases including LV aneurysm [87], severe coronary artery disease 
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with stenosis of at least 50% of one main branch coronary artery [57, 62], and 
myocarditis resulting from dengue fever [157]. The search for associations of LVNC 
and neuromuscular or metabolic disorders, has revealed an association of LVNC and 
dystrophinopathy, dystrobrevinopathy, laminopathy, zaspopathy, myotonic dystrophy, 
infantile glycogenosis type II (Pompe’s disease), myoadenylatedeaminase deficiency, 
Friedreich ataxia and Charcot-Marie-Tooth, mitochondrial disorders and Barth 
syndrome [3, 76, 85, 97, 129, 158], and it is recommended that all patients suspected 
of having LVNC also undergo a neuromuscular screening. [144]. 
As mentioned above, LVNC cases have frequently been misdiagnosed on 
initial examination, and confused with myocarditis [37, 62], restrictive cardiomyopathy 
[62], hypertrophic cardiomyopathy [11, 34, 35, 60, 71, 75, 78], hypertensive 
cardiomyopathy with prominent trabeculations [159], candida sepsis [159], 
intramyocardial hematoma [78], cardiac metastasis [78], apical cardiomyopathy [37, 
38, 66, 74, 103], apical mass/thrombus [34, 49, 62, 74], or endomyocardial fibrosis 
[37, 49, 62, 74].  
The wide variety of cardiac and other diseases noted to occur together with 
LVNC suggests that LVNC may be an architectural change that occurs in response 
to factors associated with cardiac disease in general, or may be an incidental finding 
[67].  
 
1.10     Hypothesis and aim of study 
 
As highlighted in the above discussion, a noncompaction-like increase in 
prominence of trabeculae (with resultant increased compaction ratio) may occur as a 
result of haemodynamic perturbations. The compaction ratio is the only non-
subjective diagnostic criterion for LVNC, and is widely used to diagnose congenital 
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LVNC. If however this compaction ratio is sensitive to changes in haemodynamic 
status it should be interpreted with caution when used to diagnose a so–called 
congenital cardiomyopathy. However, the relationship between LV dimensions and 
compaction ratio has not been formally studied. The aim of the present study was 
therefore to determine whether there is a relationship between the compaction ratio 
and LV cavity size and mass, in patients with congenital and acquired heart disease 
associated with known chronic increases in volume loads. To achieve this aim I 
assessed the relationship between a number of indices of volume preload on the 
heart and the compaction ratio in children and adolescents with VSDs and mitral 
valve regurgitation attributed to rheumatic heart disease (RHD). 
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CHAPTER 2 
METHODS 
56 
2.1 Justification for the study population selected  
 
To test the hypothesis that volume preload is associated with the 
compaction ratio I elected to study two groups of patients with cardiac pathology, one 
congenital and one acquired. Both are well recognized as being associated with an 
increased LV preload. In this regard, left to right shunts in VSDs lead to an increased 
pulmonary venous return and hence a volume load on the LV [32]. Similarly, in 
chronic RHD, mitral valvular regurgitation results in an increased volume load on the 
LV [160, 161]. Both LV internal diameter and LV mass are related to the size of left to 
right shunts in VSDs [162], and the severity of chronic valvular regurgitation in RHD 
[160, 161, 163]. Thus, in both VSDs and RHD with mitral regurgitation, measurement 
of LV internal diameter (LVEDD) and LV mass (LVM) serves as an index of volume 
preload. Moreover, as indicated in the introductory chapter to this dissertation, LVNC 
occurs in association with both VSDs, and mitral valve abnormalities either 
congenital or acquired. Consequently, in the present study I evaluated the 
independent relationship between LVEDD or LVM and the compaction ratio in a 
paediatric population with either VSDs or RHD. 
 
2.2 Study participants 
 
One hundred children with VSDs and thirty six with chronic RHD and mitral 
regurgitation were enrolled in this study. Patients with VSDs and RHD were 
compared with a group of 79 healthy controls. The 79 control subjects were referred 
for assessment of cardiac murmurs, chest pain, or screening for heart disease. On 
clinical examination, history, electrocardiogram, chest X-ray and echocardiography 
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they were found to have normal hearts. All participants were sequentially recruited 
from the Paediatric Cardiology Outpatient Department of the Johannesburg Hospital. 
Participants gave written informed consent. All data was collected between June 
2004 and March 2007.  
Patients with VSDs were included if they had an adequate echocardiographic 
assessment of VSD size, LV dimensions and myocardial measurements. 21 were not 
included in the study due to poor quality echocardiograms. None had prior surgical or 
spontaneous closure of their VSD. The majority had isolated VSDs while eleven had 
an additional secundum atrial septal defect (ASD) or a patent ductus arteriosus 
(PDA). These patients were included in the analysis as frequently additional shunts 
such as ASDs and PDAs are associated with larger VSDs, and hence by excluding 
non-isolated VSDs I would have prejudiced the study towards smaller VSDs. 
Nevertheless, the presence of an additional shunt was adjusted for as a confounding 
variable in the statistical analysis. Inlet VSDs were included, but complete 
atrioventricular septal defects, any form of inflow or outflow tract obstruction or 
complex heart lesions with VSDs were excluded. Patients with syndromes were 
included, but because some reports have suggested that LVNC is found more 
frequently in patients with syndromes, the presence of a syndrome was also adjusted 
for in statistical analyses. Although large, unoperated VSDs were included, none of 
the patients had suprasystemic pulmonary artery pressures resulting in a 
predominant right to left shunt (Eisenmenger). 
Children and adolescents with RHD were included if they had an adequate 
echocardiogram which included assessment of the severity of the rheumatic 
involvement, a measurement of ventricular dimensions and systolic function, and a 
measurement of the compaction ratio. Three children were not included in the study 
due to poor quality echocardiograms. Thirteen patients had had surgical repairs or 
replacement of the mitral and/or aortic valves. Two had had prior balloon mitral 
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valvuloplasties, and one surgical valvotomy No participants in any group had 
symptoms or signs of neuromuscular disease. 
Post operative rheumatic heart patients were included because although 
surgery should have relieved the underlying volume load, most RHD patients post 
operatively do have a residual MR and in some cases AR. Furthermore the inclusion 
of postoperative patients into the statistical sample added to the heterogeneity of the 
group and therefore increased the strength of the relationships demonstrated.   
Whilst the principal focus of the present study was on patients with a known 
cause of increased volume preload, i.e. VSD and RHD, the compaction ratio was 
also measured in other patients with dilated ventricles, as part of their routine 
echocardiograms. Thus several patients with dilated cardiomyopathy due to human 
immunodeficiency virus or of unknown aetiology, and an increased compaction ratio 
were also identified. These participants were not included in the overall analysis, but 
rather reported on in the present dissertation as a series of case studies summarised 
in Table 1.3 to underscore the role of the “undulating” LVNC phenotype. In some 
cases treatment resulted in improved chamber size and function (See Table 1.3). 
 
2.3 Demographics, anthropometric measurements and 
clinical data 
 
 Date of birth, gender, and the previous medical and surgical history were 
recorded in all participants. Body height and weight were measured at the time of 
echocardiography with the participants standing and wearing indoor clothes with no 
shoes. Body mass index (BMI) was calculated as weight in kilograms divided by the 
square of height in meters. Body surface area (BSA) was calculated using the 
Mosteller formula as BSA (m²) = ([Height (cm) x Weight (kg) ]/ 3600 )½. All patients 
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had previously been screened for additional pathology from a clinical history and 
examination.  
 
 
2.4 Echocardiography 
 
Echocardiograms were performed using a GE Vivid 5 ultrasound device 
(model number SN3346VM). Appropriate phased array transducers with frequencies 
ranging from 2.5 to 10Mhz were chosen in each case. Image optimization including 
frequency, depth, gain and scale settings was used in all cases. In larger patients 
tissue harmonic imaging was employed to obtain optimum images. All measurements 
were performed by a single, experienced operator (V Hunter). Still frame images and 
video footage were recorded. A complete 2-dimensional, M-mode, colour flow and 
spectral Doppler imaging echocardiogram was performed in each case. Left 
ventricular dimensions, including LVEDD and systolic internal diameter, posterior wall 
thickness and septal wall thickness were measured using two-dimensional directed 
M-mode imaging according to standard criteria [164]. The largest diameter of the LV 
was considered to be the LVEDD. LVEDD was indexed for body size using BSA0.5, 
(LVEDDI) according to the recommendations of Gutgesell et al.[165] 
To determine LV chamber and myocardial systolic function, LV endocardial 
(LV FSend) and midwall (LV FSmid) shortening fractions of the LV respectively were 
calculated using standard formulae [32, 166] viz.  
LV FSend (%) = [LVEDD – LVSD/LVEDD] x 100, * 
LV FSmid (%) = [(LVEDD+PWT)-(LVSD+PWT)/LVEDD+PWT]x100).* 
* where LVSD is LV systolic diameter and PWT is posterior wall thickness at either 
end diastole or end systole. 
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In addition, to determine LV chamber systolic function, LV volume was 
calculated using the Teichholtz formula [167] V=[7.0/2.4+D](D3), from m-mode 
measurements of systolic and end diastolic internal diameters, just beyond the tip of 
the mitral leaflets, and ejection fraction (LVEF) was derived using the formula:  
LVEF(%) = [LVDV – LVSV /LVDV] x100.* 
* where LVDV is LV diastolic volume, and LVSV is LV systolic volume. 
Relative wall thickness was calculated using the formula: 
 RWT= PWT/½LVEDD  
Left ventricular mass (LVM) was calculated from M-mode measurements obtained, 
according the method of Devereux et al (1986), viz. 
LVM (g)=0.8(1.04[(LVEDD+PWT+IVST)3 – (LVEDD)3]+1.06) * 
* where IVST is interventricular septal thickness, and indexed to BSA1.5 (LVMI), in 
accordance with the method of de Simone et al 1992 [168]. Although the use of this 
standard calculation of LVM from m-mode measurements assumes a certain 
geometry of the LV myocardium, and has not been validated in patients with LVNC 
[8], we nevertheless elected to use the calculation, with reservations, because it has 
previously been employed in patients with VSDs and RHD [162, 163, 169]. Left 
ventricular end diastolic diameter or LVEDDI, LVM or LVMI and VSD size (see 
below) were all considered indicators of LV volume load. 
Z scores of were calculated for LVEDD/ BSA0.5 and LVM/ BSA1.5 using the 
equation: 
Z = ( -  )/ s    where X is LVEDD or LVM,  is mean LVEDD or 
LVM of control group, and s is standard deviation of the control group. 
 
2.4.1 Measurement of the compaction ratio 
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In their original description of measurement of the compaction ratio, Jenni et 
al indicated that it is measured in the short axis view in systole, at the position of 
maximal thickness of the trabecular layer [9]. In the present study we elected to 
measure the compaction ratio in the same position for all patients viz. on the 
posterior wall in systole, in the LV short axis between the base of the papillary 
muscles and the apex of the heart (Figures 2.1 a, b, c). This echocardiographic 
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Figure 2.1 Apical short axis view of the left ventricle in (A) normal, control compaction ratio = 1.4, (B) ventricular septal defect, compaction 
ratio= 2.6 and (C) rheumatic heart disease, compaction ratio= 3.7, demonstrating measurement of the compaction ratio. 
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Figure 2.2. Short axis view showing echo-dense band. Repositioning of 
transducer allows for clearer differentiation of compact layer. 
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view is generally employed to demonstrate the extent of LVNC, [5, 6, 33, 38, 40, 46, 
76, 92, 98, 108, 141, 152] and to measure the compaction ratio [9, 12, 49, 67, 141]. 
Furthermore the measurement of the compaction ratio at the posterior wall in the 
short axis has the advantage of best axial resolution for distinguishing the two layers. 
Moreover it avoids the bases of the papillary muscles as a potential pitfall in 
measuring the thickness of the trabecular layer. It is usually also the position of the 
most prominent trabecular layer. The ratio is measured in systole because the 
borders of the two layers are best defined in systole, while the recesses between the 
trabeculae are best appreciated in diastole. In accordance with currently accepted 
criteria a compaction ratio >2.0 was considered to be increased [9]. A short axis view 
with the most circular LV shape was sought and off axis and oblique views were 
disregarded. Oblique views were discarded as they may include measures of the 
length of individual trabeculae, rather than the thickness of the composite trabecular 
layer. Furthermore, an echo-dense band near the apex sometimes made 
differentiation of the two layers uncertain, but careful repositioning of the transducer 
usually resolved this issue (Figure 2.2). 
In patients with a markedly trabecular myocardium the compact layer was 
occasionally difficult to discern, as noted by Kohli et al [67]. However, in our 
experience a little patience with imaging usually allowed for measurement of both 
layers. 
 
2.4.2 Segmental analysis 
 
As indicated in the introductory chapter to this dissertation, LVNC is 
considered to occur where there is both an increase in the number of trabeculae and 
an increase in the prominence of the trabeculae, i.e. trabeculae occupy a greater 
than normal volume of the LV chamber. Accordingly, although not strictly a criterion 
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for identifying LVNC, LVNC may nevertheless also be identified from an increased 
number of segments of the LV wall that are noted to have prominent trabeculation [8, 
16, 19, 62]. A typical distribution of prominent trabeculation has been published [8, 9, 
16, 19, 62], but a diagnostic threshold number of segments involved has not been 
established. In the present study it was nevertheless of interest to compare the 
distribution of segments with prominent trabeculation in both VSDs and RHD, with 
those published in cases of isolated LVNC. To achieve this, the appearance of the 
myocardium in still frame images was analysed, and a 9 segment model of the LV 
was used i.e. apical, apical septal lateral, posterior and anterior wall segments, and 
mid LV septal, lateral anterior and posterior wall segments. Each segment was 
graded as having no trabeculae, mildly prominent trabeculae or marked 
trabeculation. 
In order to asses how often a compaction ratio greater than 2 corresponded to 
an appearance of excessive prominent trabeculation, a subjective assessment of the 
degree of trabeculation was determined in each patient, where the degree of 
trabeculation was assessed as either mild, moderate or marked.  
 
2.5 Classification of congenital and acquired lesions 
 
Ventricular septal defects were categorized by position as a) perimembranous 
i.e. lying primarily in the perimembranous region, with or without extension into the 
muscular septum, b) malaligned i.e. with some degree of posterior outlet septal 
deviation, but without LV or RV ventricular outflow tract obstruction, c) high outlet i.e. 
occurring at, or above the crista supraventricularis, and closely related to both the 
aortic and pulmonary valves (also known as subarterial or doubly committed VSDs), 
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or d) muscular VSDs which were confined to the trabecular portion of the 
interventricular septum. 
For convenience of comparison, VSDs were also subdivided into groups of 
small, medium or large. The size of a VSD was measured using two-dimensional 
echocardiography, and compared to the size of the aortic annulus. In VSDs 
undergoing aneurismal closure or partially closed by prolapse of aortic valve leaflets, 
the present effective VSD size was used. Small VSDs were considered to be < 1/3 of 
the size of the aortic annulus, medium sized  1/3 but < 2/3 of the size of the aortic 
annulus, and large  2/3 of the size of the aortic annulus. 
Patients with rheumatic heart disease were classified as having mild mitral 
regurgitation (MR) based on the presence of a small colour jet with a narrow origin, 
minimal left atrial dilatation, and low pulmonary pressures; moderate or severe MR, 
when a larger jet filling greater than one third of the left atrium and left atrial dilatation 
were noted; mixed mitral valve disease (MR and mitral stenosis) when thickening and 
doming of the mitral leaflets, colour Doppler turbulence of flow across the valve, and 
reduced mitral valve orifice area were noted. In addition mitral regurgitation was 
present in all three cases of mitral stenosis. Mixed mitral and aortic regurgitation (AR) 
was defined as when in addition to mitral regurgitation there was moderate or severe 
aortic regurgitation. The degree of AR was assessed as moderate or more using a 
combination of size of colour Doppler jet, height of jet as a ratio of LV outflow tract 
diameter >1/3, and slope of continuous wave Doppler < 300ms. No patients had 
isolated aortic regurgitation or aortic stenosis. Post operative patients were classified 
according to whether they had repair or replacement of either mitral or aortic valves. 
The presence of a syndrome was included as an independent variable in the 
statistical analysis, because in the past it was thought that there may have been an 
association of syndromes with LVNC.  
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2.6 Intraobserver variability 
 
Intraobserver variability was assessed in a subset of 38 subjects in whom 
repeat echocardiographic measurements were performed by the same operator 
within a two week period of the initial measurements. The Pearson’s correlation 
coefficients for LVEDD, LVMI, trabecular layer thickness, compact layer thickness 
and compaction ratio were 0.99, 0.76, 0.89, 0.78, 0.84 (p<0.0001 in all) respectively. 
The variances (mean % difference ± SD) were -0.77±5.98%, 5.12±79.17%; 4.42± 
17.33%; 00.56±21.58%; and 4.95±24.23% respectively. In addition no significant 
differences between repeat measurements were evident on paired t-test analysis. 
(p=0.90, 0.57, 0.07, 0.82, 0.28) respectively. 
 
2.7 Data analysis 
 
Database management and statistical analyses were performed with SAS 
software, version 9.1 (The SAS Institute Inc., Cary, North Carolina, USA). Data from 
individual subjects were averaged and expressed as mean ± 95% confidence 
intervals. The 2-statistic was used to compare proportions between the three groups 
(RHD, VSD, control). Comparisons in ventricular size, morphology and function 
between the three groups were performed using analysis of variance (ANOVA) 
followed by an appropriate post hoc test (Student Newman-Keuls), and including 
age, sex and body surface area as confounding variables. Relationships between 
compaction ratios and potential determinants were assessed by multivariate stepwise 
regression analyses, in which potential determinants and adjustors [age, gender and 
BSA (where appropriate)] of the compaction ratio, were forced into the regression 
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equations. As LVM and LVEDD were closely related to each other, the relationships 
of these with compaction ratios were determined in separate models. 
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CHAPTER 3 
RESULTS 
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3.1  General demographic and anthropometric characteristics  
 
Table 3.1 shows the demographic, anthropometric and clinical characteristics 
of the study groups. When comparing demographic and anthropometric data, 
children and adolescents with RHD were older (mean age 12.9 years, range 5-
17years), and hence heavier and taller (greater BSA) than those with VSDs (mean 
age 4.3 years, range 1day-17years) or the control group (mean 4.1years, range 24 
days-15 years). Mean BMI was in the normal to low range for all three groups i.e. 
normal (16.1±0.5), VSD (15.4±0.7) and RHD (18.0±1.1). The gender distributions in 
the 3 groups were very similar. The ethnic group was black in 89%.  
 
3.2 Left ventricular internal diameters, mass and geometry 
 
Table 3.2 shows the general echocardiographic characteristics of the study 
groups. Figure 3.1 shows LVEDDI and LVMI for the three study groups. Consistent 
with either adverse LV remodelling or an increased LV preload, patients with both 
VSDs and with chronic RHD had an increased LVEDD and LVEDDI as compared to 
healthy controls. (Table 3.2). The mean z-score for LVEDDI for VSDs was 0.74, and 
for RHD was 0.77. However, there was no significant difference in LVEDDI between 
patients with VSDs and those with RHD (Figure 3.1).  
Patients with VSDs and RHD also had an increased LVM and LVMI (Table 
3.2 and Figure 3.1), as compared to the control group. (p<0.0001 for both). The Z-
score for LVMI for VSDs was 1.0, and for RHD was 0.7. However, there was no  
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 Table 3.1. Demographic and anthropometric characteristics of the study subjects 
 
 Controls (n=79)  VSD (n=100) RHD (n=36) 
Age (years) 4.1 (3.1-5.1) 4.3 (3.4-5.2) 12.9(12.0-14.0) ‡* 
Gender (% female) 49 49 39 
Race (%black) 93 84 95 
Height (cm) 90.9(83.0-98.8) 93.6(87.2-100.1) 151.6(146.5-156.8) ‡* 
Weight (kg) 15.7(12.9-18.5) 16.0(13.2-18.7) 42.5(37.6-47.4) ‡* 
Body surface area (m2) 0.62 (0.53-0.70) 0.63(0.56-0.7) 1.33(1.23-1.42) ‡* 
Body mass index (kg/m2) 16.1(15.6-16.6) 15.4(14.7-16.9) 18.0(16.8-19.2) †* 
 
Mean (95% confidence intervals). VSD, ventricular septal defects; RHD, rheumatic 
heart disease.  
† p<0.01 vs. controls; ‡ p<0.0001 vs. controls; * p<0.0001 vs. VSD. 
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Table 3.2. General echocardiographic parameters in subjects 
 
 Controls (n=79)  VSD (n=100) RHD (n=36) 
LV Mass (g) 43.4 (35.0-51.7) 58.7 (48.4-69.0)** † 173.3 (150.9-195.8)‡ 
LVM/ BSA1.5 92.5 (52.4-160.2) 129.3 (49.0-232.6) ‡ 117.2 (51.1-224.1) ‡ 
LVEDD (mm) 29.3 (27.4-31.2) 33.3 (31.3-35.3) †** 50.7 (47.4-54.1) ‡ 
LVEDD/ BSA 0.5 (mm/m0.5) 39.4 (27.9-50.1) 44.3 (34.5-58.4) ‡ 44.6 (31.7-69.0) † 
PWT/ BSA 0.5 (mm/m0.5) 6.9 (4.4-10.2) 7.5 (4.5-12.1) † 7.7 (4.5-11.8) † 
LV RWT 0.35 (0.34-0.38) 0.35 (0.33-0.37) 0.37 (0.33-0.40) 
LV ejection fraction (%) 68.7 (67.3-70.1) 69.4 (67.9-71.0)** 64.5 (61.8-67.2) † 
LV FSend (%) 37.2 (36.0-38.3) 38.1 (36.9-39.3) 35.2 (33.1-37.2) 
LV FSmid (%) 25.3 (23.9-26.7) 24.0 (22.7-25.2) 22.8 ( 20.6-24.9) † 
 
Mean (95% confidence intervals). LV, left ventricle; BSA, body surface area; EDD, 
end diastolic diameter; PWT, posterior wall thickness; RWT, relative wall thickness; 
FSend, endocardial fractional shortening; FSmid, midwall fractional shortening.  
† p<0.05 vs. controls; ‡ p<0.001vs controls, * p<0.05 vs. RHD, ** p<0.001 vs. RHD. 
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significant difference in LVMI between patients with VSDs and those with RHD 
(Figure 3.1).  
Posterior wall thickness indexed to BSA 0.5 was increased in patients with 
VSD and RHD compared to controls, however relative wall thickness values did not 
differ significantly between the groups. A relative wall thickness < 45 is considered 
normal [170] and all three groups fell below this level. 
3.3 Systolic left ventricular function 
 
The mean values for LV FSend, and LV FSmid in patients with VSDs and 
RHD were unchanged as compared to healthy subjects (Table 3.2). However in RHD 
the mean EF was normal, but lower than VSDs and the control group. (p=0.005 vs. 
controls, and p=0.0007 vs. VSDs) In the RHD group the LVEF was a determinant of 
the compaction ratio (partial r=0.31, p=0.03) (Table 3.9). Furthermore, in the control 
group a borderline significance level (partial r=0.22, and p=0.05) was found between 
the compaction ratio and the LV shortening fraction. 
In the group with RHD, 4 out of 36 patients had a lower than normal systolic 
function (LVEF< 57%) (3 post mitral valve surgical repair and one post balloon mitral 
valvuloplasty). 
In the patients with VSDs, despite increased LV internal chamber diameters 
(Figure 3.1), systolic chamber and myocardial function was preserved. This is a well 
documented phenomenon attributable to offloading of the ventricular volume into the 
lower pressure RV chamber in systole [171]. In our patient cohort with VSDs, 5 out of 
100 had a lower LVEF (<57%), and no VSDs were post operative. None of the 
control group had a diminished systolic function. 
74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Left ventricular end diastolic diameter indexed (LVEDD/BSA0.5) and mass 
indexed (LVM/BSA1.5) in normal controls, patients with ventricular septal defects 
(VSD) and chronic rheumatic heart disease (RHD) with mitral regurgitation.  
† p<0.05 vs. controls; ‡ p<0.001vs controls 
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3.4 Relationship between the size of ventricular septal 
defects and LV internal dimensions, mass and systolic 
function 
 
Table 3.3 shows LV chamber dimensions, mass and function parameters in 
patients with VSDs grouped according to VSD size. Figure 3.2 shows LVEDDI, 
LVEF, LVMI, LV FSend and LV FSmid values in patients with VSDs grouped 
according to VSD size. The majority (70%) of patients with VSDs had small VSDs 
(less than 1/3 the size of the aortic root). Consistent with the notion that in the 
absence of severe pulmonary hypertension the size of the VSD determines the 
volume of the left to right shunt, the volume increase of pulmonary venous return, 
and therefore the volume load on the LV, a strong relationship was noted between 
VSD size and both LVEDDI (p<0.0001) and LVMI (p<0.0001) in separate multivariate 
regression analysis (Figure 3.2). When placed in the same multivariate regression 
model, LVMI had the stronger relationship (p<0.0001, vs. 0.38). No relationship was 
noted between VSD size and LVFS (either end or mid), however, a negative 
relationship was noted between LVEF and VSD size. (p=0.003), i.e. patients with 
larger VSDs had poorer ejection fractions. Thus VSD size was closely related to 
LVEDDI, LVMI and systolic function.  
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Table 3.3. Left ventricular dimensions, mass, and function in children with ventricular 
septal defects grouped according to size of the defect. 
 
 Small (n=70) Medium (n=9) Large (n=21) 
LVEDD absolute (mm) 33.9 (31.8-36.0) 29.7 (23.1-36.3) 33.0 (26.6-39.3)* 
LVEDD/BSA0.5 (mm/m0.5 ) 42.2 (32.0-53.7) 45.4 (35.2-62.2) 50.9 (38.5-66.5)† 
LVM absolute (g) 58.6 (48.5-68.8) 39.2 (20.7-57.6)* 67.4 (30.4-104.4)** 
LVM /BSA 1.5(g/m1.5) 104.5(46.0-179.3) 134.3 (52.3-239.4)* 209.6 (116.9-364.0)†‡ 
LVEF (%) 70.2 (68.5-71.9) 71.0 (66.6-75.4) 66.1 (61.6-70.7)* 
LV FSend (%) 38.8 (37.3-40.2) 38.7 (35.1-42.2) 35.6 (32.3-39.0)* 
LV Fsmid (%) 24.3 (23.0-25.6) 24.7 (0.9-28.6) 22.6 (18.6-26.6) 
 
Mean (95% confidence intervals) Small: VSD diameter < 1/3 of aortic annular 
diameter; Medium: VSD diameter >1/3 but <2/3 of aortic annulus; Large: VSD > 2/3 
of aortic annular diameter; LVEDD, left ventricular end diastolic diameter; LVM, left 
ventricular mass, LVEF, LV ejection fraction; FSend, LV endocardial fractional 
shortening; FSmid, LV midwall fractional shortening. 
* p<0.05 vs. small VSDs, † p<0.0001 vs. small VSDs, ‡ p<0.0001 vs. medium VSDs. 
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Figure 3.2. Left ventricular end diastolic diameter indexed (LVEDDI), left ventricular 
mass index (LVMI), ejection fraction (EF), endocardial fractional shortening (FSend) 
and midwall fractional shortening (FSmid) in patients with ventricular septal defects 
(VSD) grouped according to VSD size. 
* p<0.05 vs. small VSDs, † p<0.0001 vs. small VSDs, ‡ p<0.0001 vs. medium VSDs. 
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3.5 Relationship between position of the VSD, presence of 
additional shunts or syndromes, and LV internal 
dimensions, mass and systolic function 
 
Table 3.4 shows LVEDDI, LVMI and systolic function in patients with VSDs 
grouped according to the type of VSD, or the presence of an additional shunt or 
syndrome. The majority of VSDs were perimembranous or muscular. The position or 
associated characteristics of the VSDs did not significantly influence LVEDDI, LVMI 
or systolic function. Of 23 patients in the muscular VSD group, 13 patients had small 
VSDs, 3 had moderate, and 7 had large. However, as can be seen in table 3.4, the 
muscular VSDs, had a lower mean LVEDD/BSA 0.5 than any of the other groups, 
indicating that the association of muscular VSDs and LV trabeculation was probably 
not due to volume loading, and unrelated to VSD size. There is a weak statistical 
association of muscular VSDs and compaction ratio, which may have become 
stronger with a larger sample size. The possible connection between muscular VSDs 
and noncompaction, unrelated to volume load is addressed in sections 1.9.1, and 
4.7.   
There was no statistically significant difference in LV chamber size, mass and 
function in patients having an additional ASD or PDA compared with those who did 
not. 
In the group with VSDs, 14 patients had syndromes of which 10 were Down 
syndrome. In the control group, 8 children had syndromes, of which 6 were Down 
syndrome. The presence of a syndrome was not associated with any changes in 
LVEDDI, LVMI, or LV systolic function. The objective of including syndromic patients 
as a separate group was to determine whether there was an association of 
syndromes with increased compaction ratio independent of the size of the VSD, 
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LVEDD, LVM and function (there was not) and therefore I deemed it unnecessary to 
further divide the syndromic patients into groups of VSD size. Furthermore 
subdivision of the syndromic patients by VSD size would have would have resulted in 
underpowered statistical analysis. 
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Table 3.4. Left ventricular dimensions, mass, and function in children with ventricular septal defects (VSD) grouped according to position and 
associated features of the defect 
 
 n= LVEDD/BSA0.5 
(mm/m0.5 ) 
LVM/BSA1.5 (g/m1.5) LVEF  
(%) 
LV FSend (%) 
Perimemb 59 45.3 (34.8-62.2) 129.6 (51.2-239.4) 69.7 (67.6-71.8) 38.5 (36.8-40.1) 
Muscular 23 42.2 (31.5-53.4) 132.0 (45.8-208.4) 68.6 (64.5-72.6) 37.1 (34.1-40.2) 
Malaligned 8 45.8 (38.6-57.1) 128.7 (60.5-209.2) 70.8 (64.0-77.5) 39.4 (33.1-35.6) 
High outlet 10 42.5 (35.2-55.5) 121.4 (67.2-364.0) 68.7 (65.9-71.50 37.1 (34.4-39.8) 
+Shunts 11 44.3 (29.0-57.8) 157.5 (46.1-306.2) 71.5 (63.8-79.1) 39.5 (33.4-45.7) 
Syndromic 14 41.9 (29.0-55.9) 119.3 (24.7-199.3) 73.8 (60.0-86.0) 41.7 (31.0-54.0) 
 
Mean (95% confidence intervals) Perimemb, perimembranous; +Shunts, VSD with additional atrial septal defect and or patent ductus 
arteriosus, LVEDD, left ventricular end diastolic diameter; LVM , left ventricular mass, LVEF, LV ejection fraction; FSend, LV endocardial 
fractional shortening. 
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3.6 Relationship between mitral valve defect and LV internal 
dimensions, mass and systolic function 
 
Table 3.5 shows LVEDDI, LVEF, LVMI, and LV FSend values in patients with 
RHD grouped according to the mitral valve pathology. Although patients with severe 
mitral regurgitation or additional aortic regurgitation had a greater LVEDDI and LVMI, 
the mitral valve pathology was generally too heterogeneous to show clear relations 
with either LVEDDI, or LVMI. While LVEF in severe MR was different from mild MR 
(p<0.05), LV FSend did not differ between the groups. 
 
3.7 Impact of congenital and acquired cardiac pathology on 
the compaction ratio of the left ventricle 
 
Table 3.6 shows the mean thickness of the trabecular and compact layers and 
the compaction ratios in the study groups. Figure 3.3 illustrates the multivariate 
adjusted mean thickness of the trabecular and compact layers and the compaction 
ratios in the study groups. As compared to healthy controls (compaction 
ratio=1.4±0.08) patients with VSDs (compaction ratio = 2.0±0.2, p<0.0001) and RHD 
(compaction ratio = 2.0±0.3, p< 0.0001) had a marked increase in the compaction 
ratio. After adjustment for age, BSA and gender, there was no difference between 
compaction ratios of patients with VSDs as compared to those with RHD. 
A compaction ratio >2 was found in 42% of patients with VSDs and 47% of 
patients with RHD. Of the 79 controls, 4 (5%) had a compaction ratio >2 but 2.2. 
Although the adjusted mean thickness of the compact layer was not different 
between the groups (Figure 3.3), the adjusted mean thickness of the trabecular layer  
82 
Table 3.5. Left ventricular dimensions, mass, and systolic function in children with rheumatic heart disease grouped according to the valvular 
pathology and the surgical procedure 
 
 
 
Means (95% confidence intervals) MR, mitral regurgitation; AR, aortic regurgitation; MS, mitral stenosis; LVEDD, left ventricular end diastolic 
diameter; LVM, left ventricular mass, LVEF, LV ejection fraction; FSend, LV endocardial fractional shortening.  
* p<0.05 vs. mild MR, † p, 0.05 vs. post surgical patients, and ‡ p<0.05 vs. mixed MR/MS. 
 n LVEDD/BSA0.5 
(mm/m0.5 ) 
LVM/BSA1.5  
(g/m1.5) 
LVEF (%) FSend (%) 
Mild MR 6 40.2 (33.9-47.9) 78.0 (51.1-107.4) 70.0 (63.6-76.4) 39.2 (34.4-44.0) 
Mod/severe MR 9 53.4 (38.9-71.7)*†‡ 154.5 (51.1-224.1)* † 61.0 (53.5-68.5)* 33.3 (28.4-38.3) 
Mixed MR/MS 3 38.0 (34.6-42.0) 107.4 (88.4-134.6) 64.0 (42.8-85.2) 33.3 (10.9-55.7) 
MR+AR 5 54.0 (47.6-60.6)*†‡ 162.3 (114.5-227.0)* † 66.0 (61.5-70.5) 36.6 (33.0-40.2) 
Post surgical  13 39.0 (29.1-50.2) 99.5 (67.3-215.4) 63.9 (58.8-69.0) 34.5 (30.6-38.5) 
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Table 3.6. Thickness of the trabecular and compact layers of the left ventricle and 
the ratios between the thickness values of these layers in study subjects 
 
 Controls (n=79)  VSD (n=100) RHD (n=36) 
Compact layer (mm)adj* 5.15 (4.58-5.66) 4.92 4.69-5.17) 5.37 (4.88-5.86) 
Trabecular layer (mm)adj* 7.02 (6.22-7.81) 9.28.50-9.90)‡ 11.49.95-12.83)‡ 
Compaction ratio 1.4 (1.3-1.5) 2.0 (1.8-2.2)‡ 2.0 (1.7-2.3)‡ 
 
Mean (95% confidence intervals) VSD, ventricular septal defect; RHD, rheumatic 
heart disease. * Adjusted for age, BSA, gender.  
‡ p<0.0001 vs. controls 
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Figure 3.3. Multivariate adjusted trabecular and compact layer thickness values and 
compaction ratio in patients with ventricular septal defects (VSD) and chronic 
rheumatic heart disease (RHD) with mitral regurgitation. 
* p< 0.0001 vs. controls. 
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was increased in patients with VSDs and RHD (Figure 3.3). Therefore, an increase in 
the trabecular layer thickness was the major determinant of the increase in the 
compaction ratio. 
In keeping with the relationship between VSD size and compaction ratio, a 
greater number of the patients with moderate and large VSDs had compaction ratios 
over 2 (Table 3.7). Furthermore 9 of the 11 patients (82%) with an additional shunt 
i.e. a patent ductus arteriosus or atrial septal defect, had a compaction ratio >2 
(Table 3.9). Muscular VSDs demonstrated a trend towards higher compaction ratio 
as compared with VSDs in other positions (p<0.05 vs. perimembranous VSDs) 
(Table 3.9). In 15/23 (65%) of muscular VSDs the compaction ratio was >2.0, whilst 
20/59 (33%) of perimembranous, 3/8 (38%) of malaligned and 4/10 (40%) of high 
outlet VSDs had a compaction ratio >2.0 (Table 3.7). The presence of a syndrome 
was not significantly associated with the compaction ratio, but 7/14 (50%) patients 
with syndromes had compaction ratios >2.0 (Table 3.7). In the control group a single 
syndromic patient  (with goldenhar syndrome) had a compaction ratio> 2. None of the 
control group with Down syndrome had increased compaction ratios. 
In patients with RHD when grouped according to valve pathology or surgery, 
the highest compaction ratios were encountered in the group with moderate or 
severe mitral regurgitation. (Table 3.8) Of the 36 patients with RHD, 17(47%) had a 
compaction ratio >2. The greatest proportion of patients with RHD with a compaction 
ratio >2 were in the groups with severe mitral regurgitation (66%), or with combined 
mitral regurgitation and mitral stenosis (66%) (Table 3.8). 
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Table 3.7. Relationship between size and position of the VSD, presence of additional 
shunts or syndromes, and the compaction ratio 
 
 N Compaction ratio 
(CR) 
Adjusted CR*  Proportion with 
CR>2.0 
Small 70 1.7 (1.0-3.1) 1.7 ± 0.08 18/70 (25.7%) 
Medium 9 2.4 (1.0-3.3) † 2.4±0.24† 7/9 (77.8%) 
Large 21 2.7 (1.0-4.2) ‡ 2.7 ±0.16‡ 17/21 (80.9%) 
Perimemb 59 1.9 (1.0-3.4) 1.9 ± 0.10 20/59 (33%) 
Muscular 23 2.3 (1.1-3.6) § 2.3 ± 0.17§ 15/23 (65%) 
Malaligned 8 2.1 (1.2-4.4) 2.1 ± 0.29 3/8 (37.5%) 
High outlet 10 1.9 (1.0-4.1) 2.0 ± 0.25 4/10 (40%) 
+Shunts 11 2.6 (1.0-3.4)# 2.5±0.24# 9/11 (81.8%) 
Syndromic 14 2.1 (1.1-3.3) 2.1 ±0.22 7/14 (50%) 
 
Mean (95% confidence intervals) Small: VSD diameter < 1/3 of aortic annular 
diameter; Medium: VSD diameter >1/3 but <2/3 of aortic annulus; Large: VSD > 2/3 
of aortic annular diameter; Perimemb, perimembranous; +Shunts, VSD with 
additional atrial septal defect and or patent ductus arteriosus. * adjusted for age, 
BSA, and gender.  
† p<0.05 vs. small VSDs, ‡ p<0.0001 vs. small VSDs, § p<0.05 vs. perimembranous 
VSDs, # p<0.05 vs. without additional shunts. 
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Table 3.8. Left ventricular compaction ratios and proportion of patients with 
compaction ratios >2.0 in children with rheumatic heart disease grouped according to 
the valvular pathology and the surgical procedure 
 
 N Compaction ratio 
(CR) 
Adjusted CR* 
 
Proportion with 
CR>2.0 
Mild MR 6 1.4 (1.1-2.2) 1.3 ±0.4 1/6 (16.6%) 
Mod/severe MR 9 2.7 (1.1-6.2) 2.9 ±0.3†‡ 6/9 (66.6%) 
Mixed MR/MS 3 2.1 (1.5-2.7) 1.8 ±0.5 2/3 (66.6%) 
MR+AR 5 2.3 (1.9-2.8) 1.8 ±0.4 3/5 (60%) 
Post Surgery 13 1.7 (1.0-2.8) 2.0 ±0.3 5/13 (38.5%) 
 
Mean (95% confidence intervals) MR, mitral regurgitation; AR, aortic regurgitation; 
MS, mitral stenosis; MV, mitral valve. * adjusted for age, BSA, and gender. 
† p<0.05 vs. mild, ‡ p<0.05 vs. post surgery.  
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3.8 Factors associated with the compaction ratio 
 
Table 3.9 shows the factors correlated with compaction ratios in patients 
with VSDs, RHD or normal controls as derived from univariate analysis. Figures 3.4 
and 3.5 show the correlations between either LVEDDI (Figure 3.4) or LVMI (Figure 
3.5) and the compaction ratio in patients with VSDs or RHD. On univariate analysis 
the compaction ratio was associated with LV chamber size and mass in both VSDs 
and RHD, and was furthermore associated with VSD size and additional shunts in 
the VSD group. The compaction ratio was not correlated with age, gender or BSA in 
any group. 
Table 3.10 shows the factors independently associated with compaction 
ratios in multivariate analysis as derived from stepwise regression models with 
LVEDD and LVM included in separate models. In the control group there was a 
borderline association of compaction ratio and LV FSend. In the VSD group the 
compaction ratio was most strongly associated with LVMI and VSD size, while a 
lesser relationship existed between the compaction ratio and LVEDDI and additional 
shunts. In RHD the compaction ratio was associated with LVEDDI, LVMI, and LVEF. 
Both univariate and multivariate analysis was undertaken in all three groups. 
Table 3.9 represents the univariate analysis. The relationship of the compaction ratio 
to LVEF in RHD is not significant on univariate analysis, but becomes weakly 
significant on multivariate analysis (table 3.10) p=0.03. This is likely to imply that 
there may be other factors which also have an effect causing the LVEF to become 
significant. The implication is that as stated, the relationship of the compaction ratio 
with LVEF is minor or tenuous at best. This is further discussed in 4.6 below. 
 
 
89 
Table 3.9. Factors correlated on univariate analysis with the compaction ratio in 
control subjects and patients with ventricular septal defects (VSD) and rheumatic 
heart disease (RHD). 
 
 
 
  
-coefficient 
 
Partial r 
 
P value. 
 
Control group (n = 79) 
LVM/BSA 1.5  1.39 0.01 0.88 
LVEDD/BSA 0.5  0.01 0.19 0.09 
LV EF  -0.01 0.19 0.10 
LV FSend  1.39 0.09 0.04 
 
Ventricular septal defects (n =100) 
LVM/BSA 1.5  0.01 0.42 <0.0001 
LVEDD/BSA 0.5  0.04 0.36 0.0003 
VSD size  0.07 0.40 <0.0001 
LV EF  1.99 0.11 0.3 
LV FSend  1.99 0.01 0.37 
Additional shunts  0.66 0.27 0.01 
 
Rheumatic heart disease (n = 36 ) 
LVM/BSA 1.5  0.01 0.47 0.005 
LVEDD/BSA 0.5  0.06 0.60 <0.0001 
LV EF  2.0 0.22 0.20 
LV FS end  2.0 0.17 0.33 
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Figure 3.4 Relationship between left ventricular end diastolic diameter indexed to 
body surface area (LVEDD/BSA0.5) and the compaction ratio in patients with 
ventricular septal defects (VSDs) (top) and rheumatic heart disease (RHD) with mitral 
regurgitation (below). 
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Figure 3.5 Relationship between left ventricular mass indexed (LVMI/BSA 1.5) and 
the compaction ratio in patients with ventricular septal defects (VSDs) (top) and 
rheumatic heart disease (RHD) with mitral regurgitation (below). 
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Table 3.10. Factors independently associated with compaction ratio in control 
subjects and patients with ventricular septal defects and rheumatic heart disease on 
multivariate analysis 
 -coefficient±SEM Partial r P value. 
Control group (n= 79) 
LVM/BSA 1.5* -0.0006±0.001 0.08 0.46 
LVEDD/BSA 0.5** 0.009±0.006 0.19 0.096 
LV EF** -0.040±0.020 0.17 0.13 
LV FSend 0.05 0.22 0.05 
Ventricular septal defects (n=100) 
LVM/BSA 1.5*  0.004±0.002 0.44 <0.0001 
LVEDD/BSA 0.5** 0.040±0.014 0.24 0.01 
VSD size* 0.035±0.020 0.40 <0.0001 
LV EF* 0.003±0.068 0.02 0.8 
LV FSend -0.002 0.00 0.98 
Additional shunts** 0.432±0.249 0.21 0.02 
Rheumatic heart disease (n= 36 ) 
LVM/BSA 1.5* 0.01±0.004 0.48 0.005 
LVEDD/BSA 0.5** 0.068±0.022 0.62 0.0001 
LV EF** -0.033±0.096 0.31 0.03 
LV FSend -0.001 0.00 0.99 
 
*Model includes age, gender, VSD position and size, midwall fractional shortening, 
relative wall thickness, ejection fraction, endocardial fractional shortening, additional 
shunts and syndromes, but not LVEDD. **Model includes age, gender, midwall 
fractional shortening, relative wall thickness, ejection fraction, endocardial fractional 
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shortening, and VSD position, size, and additional shunts and syndromes (in the 
VSD group), but not LVM.  
 
3.9 Segmental analysis of the LV and assessment of the 
prominence of trabeculation 
 
Figure 3.6 shows the degree of trabeculation in LV segments in patients with 
VSDs and RHD.  Patterns of trabeculation in both VSD and RHD were essentially 
similar with most prominent trabeculation in both groups being in the apical, apical-
posterior and apical-lateral segments. The only mild difference between VSDs and 
RHD is at the mid chamber level where RHD is slightly more trabeculated anteriorly 
and VSD laterally. This difference is probably insignificant, as the trabeculation at this 
level is mild. In order to determine how frequently a compaction ratio over 2 
corresponded with a subjectively assessed increase in the degree of trabeculation, 
the proportion of patients who scored as mild, moderate or severe are tabled vs. the 
compaction ratio (Table 3.11). In patients with VSDs a compaction ratio <2 was found 
in 57 patients, of whom 82% had correspondingly mild trabeculation. In these 
patients with VSDs, 31 had compaction ratios 2, but less than 3, and most (87%) of 
these had moderate or marked trabeculation. Twelve patients had ratios 3, and all 
of these, with the exception of one case appeared to have marked trabeculation. In 
the patients with RHD, 19 cases had compaction ratios less than 2, and this 
corresponded with a mild appearance of trabeculation in most (84%) cases. In the 
patients with RHD, 58% of cases with ratios 2 but <3 had moderate or marked 
trabeculation, and of 3 cases with compaction ratios  3, all had marked 
trabeculation. From these observations it is my opinion that a compaction ratio 3 is 
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more reliably associated with subjectively assessed marked trabeculation, than lower 
values. 
95 
Segmental trabeculation in VSD
0 10 20 30 40 50 60 70
Apex
Apical posterior
Apical lateral
Apical anterior
Apical septum
Mid  posterior
Mid lateral
Mid anterior
Mid septum
Se
gm
en
ts
Number of patients
Mild trabeculation
Marked trabeculation
Segmental trabeculation in RHD
0 2 4 6 8 10 12 14 16 18
Apex
Apical posterior
Apical lateral
Apical anterior
Apical septum
Mid posterior
Mid lateral
Mid anterior
Mid septum
Se
gm
en
ts
Number of patients
Mild trabeculation
Marked trabeculation
 
 
 
 
  
 
 
 
 
Figure 3.6 Segmental trabeculation in ventricular septal defects 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 Segmental trabeculation in rheumatic heart disease 
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Table 3.11 Comparison of subjective (mild, moderate and severe) and objective 
(compaction ratio) assessments of trabeculation in patients with ventricular septal 
defects (a) and rheumatic heart disease (b)  
 
 <2 2and <2.5 2.5 and <3 3 Total 
Mild 47 4 0 1 52 
Moderate 8 13 3 0 24 
Marked 2 4 7 11 24 
Total 57 21 10 12 100 
 
Table 3.11a Comparisons of subjective and objective assessments of 
trabeculation in ventricular septal defects 
 
 
 <2 2 and<2.5 2.5 and<3 3 Total 
Mild 16 2 1 0 19 
Moderate 3 6 2 0 11 
Marked 0 1 2 3 6 
Total 19 14 5 3 36 
 
Table 3.11b Comparisons of subjective and objective assessments of 
trabeculation in rheumatic Heart disease 
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CHAPTER 4 
DISCUSSION AND CONCLUSIONS 
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4.1 Background to this study 
 
As reviewed in chapter 1 of the present dissertation, the prevailing 
hypothesis for the pathogenesis of LVNC is that it is a congenital defect that exists at 
birth and remains throughout life, regardless of the haemodynamic status of the 
ventricle [8, 34, 37, 60, 70, 75]. However, as also outlined in chapter 1, LVNC may in 
some cases occur together with acquired diseases (see sections 1.6.3, 1.6.4, 1.6.5.). 
Further, temporal changes in compaction ratios or prominence of trabeculation have 
been observed [13, 76, 89, 111, 139, 140], and it has been suggested that these 
changes are related to the volume status of the ventricle [13, 44, 111]. In the present 
dissertation I hypothesised that while true LVNC may be a congenital condition in 
which the trabeculae are both more numerous and more prominent than normal, an 
LVNC–like appearance may occur due to an increased prominence of the trabeculae 
produced through volume preloads and the resultant cardiac dilatation and 
hypertrophy. To test this hypothesis I compared the compaction ratio in both 
congenital (VSDs) and acquired (RHD) cardiac pathology associated with increases 
in volume preloads with the compaction ratio noted in healthy controls. Further, I 
assessed the relationship between indices of cardiac preload (LVEDD, VSD size) or 
hypertrophy (LVMI) and the compaction ratio in patients with VSDs and RHD. 
As reviewed in chapter 1, the presence of LVNC is thought to lead to LV 
systolic dysfunction and dilatation. It might therefore be argued that an association 
between LV noncompaction and LV dilatation is expected. However, to test the 
hypothesis that dilatation of the LV might lead to a noncompaction–like appearance, 
rather than LVNC leads to dilatation and systolic dysfunction, I evaluated patients 
with cardiac pathology where volume preloads and hence cardiac dilatation are 
induced through varying pathologies i.e. VSD or valve pathology.  
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4.2 Main findings of the present study and potential 
implications thereof 
 
The main findings of the present study are as follows: In paediatric patients 
with VSDs and RHD with mitral regurgitation, who had striking increases in LVEDDI 
and LVMI, but a preserved LV systolic function in most cases, marked increases in 
compaction ratios were noted as compared to healthy controls. A high proportion 
(43%) of these patients had a compaction ratio that would be considered to reflect a 
diagnosis of noncompaction. However, a threshold value of >2 did not always 
correspond with an appearance of excessive, prominent trabeculation. Second, 
LVEDD, VSD size, LVM and EF were independently associated with the compaction 
ratio. These data therefore suggest that the compaction ratio in congenital and 
acquired cardiac pathology in children and adolescents is partly determined by 
volume preloads on the LV.  
 
4.3 Comparison with previous studies 
 
As reviewed in chapter 1, LVNC has been reported to occur in a number of 
studies in patients with VSDs and valvular disturbances. However, the present study 
is the first to evaluate whether a haemodynamic/cardiac remodelling mechanism 
may, in part, explain these findings. An enhanced prominence of trabeculae in the 
presence of dilated ventricles has previously been suggested [21, 23, 67, 106]. 
Furthermore a reduction in the prominence of trabeculae or compaction ratio, 
following improvement of LV function and decreases in chamber dimensions has 
been reported to occur [13, 111, 139]. Moreover, noncompaction-like remodelling of 
the RV has been noted in a case where the RV supported the systemic circulation 
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[172]. However, the potential role of LV volume load as a cause of apparent 
noncompaction has been refuted by some authors [49, 173], and reported cases of 
LVNC in the presence of normal LV dimensions [13, 78, 110] suggest that 
haemodynamic effects do not account for all cases of LVNC. However, no formal 
assessment of the relationship between indices of haemodynamic factors and the 
compaction ratio has been performed.  
In a recent study [67], diagnostic criteria for LVNC were assessed in a cohort of 
adults with systolic dysfunction. In that study [67] 23.6% of the cohort and 8.3% of 
normal controls met the criteria for LVNC. Moreover, a relationship between LVNC, 
diagnosed according to standard criteria and a younger age, a larger LVEDD and 
ethnicity was noted [67]. These authors [67] suggested that the diagnostic criteria for 
LVNC were excessively sensitive, resulting in an over-diagnosis of LVNC in patients 
with systolic dysfunction. The findings of the present study concur with this 
conclusion, and suggest that a reappraisal of LVNC diagnostic criteria is important. 
However, I noted an even greater incidence of an increased compaction ratio in 
patients with VSDs and RHD as compared to that reported on in adult patients with 
systolic dysfunction [67]. There may be many possible explanations for this. As 
previously indicated [67] either a paediatric age group, or black-African ethnic 
ancestry, as evaluated in the present study, might be associated with higher 
compaction ratios. However, I did not find an association between age and the 
compaction ratio, although this may be attributed to the narrow age range of the 
participants studied. More importantly, patients reported on in the present study had 
different causes of dilatation and hypertrophy as compared to those previously 
studied [67]. Furthermore in the patients with VSD, it is possible that congenital 
factors may play a role. 
The number of noncompacted segments of the LV have previously been 
shown to be negatively correlated with the LV end diastolic volume index [106]. A 
negative correlation between the number of LV noncompacted segments and LV 
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volume is at apparent odds with the finding reported on in the present dissertation of 
a clear positive association between LVEDD and the compaction ratio. However, LV 
end diastolic volume index, as determined using the Simpson biplane method, 
incorporates measures at the apex of the heart, the area where the noncompaction 
ratio is assessed. An excessively noncompacted LV may therefore reduce the 
calculated internal volume thus biasing data toward a negative correlation between 
internal volumes and the noncompaction ratio. It is for this reason that in the present 
study cavity dimensions were assessed only from the base of the heart, thus 
avoiding spurious correlations occurring because of measurements being obtained 
from the same region of the heart. 
In the present study, segmental analysis of the LV with the most prominent 
trabeculations revealed a similar pattern as that described for isolated LVNC [9, 14, 
16, 19, 62]. Thus, although not assessed in the present study, it is nevertheless 
unlikely that apparent as opposed to isolated LVNC can be determined from 
segmental analysis. 
The high incidence of a compaction ratio greater than 2 in the present study 
would at first glance appear to be at odds with the reported incidence of LVNC 
(reviewed in chapter 1). However, as demonstrated in Table 3.11, a compaction ratio 
greater than 2 often corresponded with minor increases in trabeculation as assessed 
by direct observation. These minor increases are possibly changes that may not 
reflect LVNC. 
 
4.4 Relationship between LVEDD and the compaction ratio 
 
Although it is well documented that both VSDs and chronic valvular lesions 
(mitral and aortic regurgitation) place an increased volume load on the LV, resulting 
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in an increased LVEDD and LVM [162, 174], it may nevertheless be argued that the 
independent relationship between LVEDD and the compaction ratio noted in patients 
with VSDs and RHD may reflect adverse structural cardiac remodelling (dilatation) 
rather than the extent of the volume preload on the LV. However, in the present study 
there are arguments to suggest that the relationship between LVEDD and the 
compaction ratio is attributed to a volume preload and not to adverse LV structural 
remodelling. First, in the present study, whilst the compaction ratio was related to EF 
in patients with RHD, and SF in the control group, this relationship was absent in 
patients with VSDs, and was only of borderline significance in the controls. In this 
regard, maladaptive remodelling occurs in association, for example, with myocardial 
infarction[175] where pump dysfunction coexists [176]. In contrast, in compensatory 
(adaptive) remodelling, which occurs for example in mitral regurgitation, although 
there is an increase in LVEDD, a high stroke volume is maintained and pump 
function is preserved. Thus a relationship between LVEDD and the compaction ratio, 
but not between EF and the compaction ratio in patients with VSDs suggests that the 
positive relationship between LVEDD and the compaction ratio is through 
mechanisms that are unrelated to changes in pump function. Second, independent 
relations between LVEDD and the compaction ratio in patients with either VSDs or 
RHD were noted even after adjustments for EF, a measure of systolic chamber 
function. Third, an independent relationship between VSD size and the compaction 
ratio and additional shunts and the compaction ratio was also noted even after 
adjusting for EF. 
 
4.5 Relationship between LVM and the compaction ratio 
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In the present study an independent relationship between LVM indexed to 
BSA 1.5 (LVMI) and the compaction ratio was noted in patients with both VSDs and 
RHD. As the relationship between LVEDD and the compaction ratio was abolished 
with the inclusion of LVM as a confounder in the regression analysis, it is unlikely to 
reflect a relationship between cardiac growth and increased trabecular prominence, 
independent of volume preloads. Indeed, despite an increased LVMI in both groups 
of patients, LV relative wall thickness was unchanged. Thus, LV hypertrophy in this 
cohort of patients with VSDs and RHD was eccentric in nature, a change that is 
usually associated with a volume overload [177]. Hence, the relationship between 
LVMI and the compaction ratio in the present study is again likely to reflect a 
relationship between volume preloads and the compaction ratio. 
 
4.6 Systolic LV dysfunction and the compaction ratio 
 
Heart failure is a common presentation of patients with isolated LVNC [12, 62, 
76]. Symptomatic heart failure is found in approximately two-thirds of patients with 
LVNC and frequently leads to death or transplantation [18, 102]. As outlined in 
section 1.8.2 of the present dissertation, heart failure in LVNC could occur as a 
consequence of either systolic or diastolic cardiac dysfunction or both [36, 37, 76, 78, 
109]. The reduced ventricular function in cases of LVNC with heart failure may occur 
secondary to a reduced thickness of the compact layer in relation to the trabeculated 
myocardium, in regions affected by LVNC [18]. Other hypotheses have nevertheless 
been proposed for the development of heart failure in LVNC (see introductory 
chapter). 
Despite a high prevalence of patients with VSDs and RHD with an increased 
compaction ratio in the present study, few patients had clinical heart failure at the 
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time of study, and LV EF was normal in the majority of cases. A preserved LV 
systolic function in the presence of mitral regurgitation or a VSD is considered to be 
the result of an enlarged LV diastolic volume, and a diminished systolic volume as 
the ventricle offloads into the lower pressure left atrium in the case of RHD, or right 
ventricle in VSDs [171, 174, 178]. However favourable preoperative loading 
conditions might  mask underlying myocardial dysfunction, which may in some cases 
become apparent after surgical intervention [179]. In this regard it is of interest that 
the mean mid-wall fractional shortening, which may detect latent myocardial 
dysfunction [180], was in the normal range of 22-26%, in patients with VSD or RHD. 
However a weak independent negative relationship between EF and the compaction 
ratio was found on multivariate analysis, and this was not abolished with the inclusion 
of LVEDDI in the model. Therefore systolic function was, in part, a determinant of the 
compaction ratio independent of filling volumes in patients with RHD. Since EF is 
determined by both LV diastolic and systolic volume, it is possible that a relationship 
between EF and the compaction ratio independent of diastolic diameters is an effect 
mediated by systolic volume (stroke volume), which in-turn is a function of a 
hyperdynamic circulation. 
An independent relationship between EF and the compaction ratio as observed 
in the present study supports the proposal of Lofiego et al (2006) who suggested that 
LVNC represents a marker of associated pathology rather than a primary 
pathological process [106]. Furthermore, improvement in EF following medical 
therapy, in patients with LVNC [109] suggests that the underlying congenital 
malformation associated with LVNC, which is unlikely to be affected by therapeutic 
agents, is not the main determinant of the LV systolic dysfunction in patients with 
LVNC [12]. 
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4.6.1 The role of the compact layer in preserving systolic function. 
 
Whilst speculative, I have nevertheless considered the possibility that the 
preserved LV systolic function in the majority of cases of RHD and VSD in the 
present study might be a result of a maintained thickness of the compact layer. A thin 
compact layer in isolated LVNC has previously been reported [4, 5, 6, 18], and is 
thought to contribute to LV dysfunction. Indeed, in comparative anatomical studies 
the development of the compact layer is related to the maintenance of higher blood 
pressures in larger animals, and those with active lifestyles where the heart is 
required to generate a greater force of contraction [120, 121]. In the group of patients 
studied in the present dissertation however although there was an increase in the 
trabecular layer thickness, I was unable to demonstrate thinning of the compact 
layer. This could have been due to limitations in measurement. Alternatively the 
volume load may have resulted in concentric hypertrophy with compact layer 
thickening, whilst simultaneous dilatation resulted in compact layer thinning, the net 
result being a compact layer that was unchanged. Retention of the compact layer 
thickness may have subsequently contributed to a preserved LV systolic function. 
 
4.7 The compaction ratio and VSD position 
 
The majority of VSDs in the present study were perimembranous (59%), and 
the remaining 41% were made up of muscular (23%), malaligned (8%), and high 
outlet (10%). This is in keeping with published data [181] of 80% of VSDs being 
perimembranous, 5-20% being muscular and 5-7% being high outlet. In the series of 
patients reported on in the present study 65% of muscular VSDs had a compaction 
ratio>2, as compared with 34% of perimembranous, 40% of high outlet and 37% of 
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malaligned VSDs having a compaction ratio>2. (Table 3.7) The compaction ratio in 
muscular VSDs was significantly greater than those with perimembranous VSDs 
(p<0.05) This is of interest as muscular VSDs have been described in conjunction 
with LVNC [29, 45, 84, 101] and an association of LVNC and muscular VSDs was 
noted by Lilje et al (2006) [84]. This association suggests that congenital factors may 
be playing an additional role in increasing the compaction ratio in VSDs, especially 
muscular VSDs, irrespective of the size of the left to right shunt, or LV preload. 
Indeed, experimental evidence in the chick embryo shows that the muscular septum 
is formed by the coalescence of trabecular sheets, and small muscular septal defects 
may result from incomplete compaction [147]. However, whether this can be 
extrapolated to humans and other mammals is uncertain because in the mouse 
model the formation of the interventricular septum occurs after trabecular 
compaction, and is considered to be due to the expansive growth of the apices of 
both ventricles [69]. 
 
4.8 The compaction ratio and the characteristics of the 
valvular disease. 
 
Of the 36 patients with RHD in the present study, 18 (50%) had a compaction 
ratio>2. The greatest number of patients with a compaction ratio >2.0 were those 
with severe mitral regurgitation or those with both mitral and aortic regurgitation.  
Furthermore these groups also had the largest LVEDDI and LVMI. This is entirely in 
keeping with the hypothesis that volume loads contribute to the noncompaction-like 
appearance of the myocardium.  
Two out of three patients with combined mitral regurgitation and mitral 
stenosis also had an increased compaction ratio. A raised compaction ratio in 
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patients with mixed mitral valve disease involving mitral stenosis may appear at odds 
with the notion that volume preloads contribute to noncompaction in mitral valve 
disease, and these patients had lower LVEDDI and LVMI than patients with 
predominantly regurgitant lesions. However cases of mitral stenosis and LVNC have 
previously been reported [27, 154, 155, 182]. This apparent contradiction might be 
explained in several ways. While these three patients were known to have mitral 
valve thickening and orifice reduction (i.e. mitral stenosis), we cannot be sure 
whether the  haemodynamically predominant lesion was stenosis or regurgitation. 
Indeed of the three patients, two had undergone balloon valvuloplasties, and one a 
surgical valvotomy, procedures known to result in valvar regurgitation. It has been 
reported that an increase in LV mass and LVMI may follow percutaneous mitral 
valvuloplasty for rheumatic mitral stenosis [163]. Further, it is possible that if the 
valve pathology began as mitral regurgitation prior to stenosis as typically occurs in 
the natural history of the progression of rheumatic heart disease in developing 
countries [183]. Under these circumstances, trabecular hypertrophy or proliferation 
may exist in patients with mitral stenosis not because of the stenotic valvular lesion, 
but because of previously high volume preloads resulting from mitral regurgitation. 
Alternately, an underlying pre-existing increase in trabecular thickness might 
predispose patients to developing RHD and mitral stenosis. Finally, the small number 
of patients with mixed mitral disease and increased compaction ratio could be an 
epiphenomenon due to insufficient patient numbers. 
 
4.9 Noncompaction as an adaptation to adverse 
haemodynamic conditions 
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As reviewed in 1.5.7 in the introductory chapter to this dissertation, it is 
thought that LVNC may be a compensatory change in some cardiac pathologies. 
Observations from invertebrate hearts which are predominantly trabecular, with very 
little compact myocardium, and where the heart is adapted as a specialized high 
volume, low pressure pump, suggest that particularly in cases of increased volume 
load on the ventricle during cardiac development, an increased trabecular pattern 
might occur. Finding a raised compaction ratio in the presence of acquired cardiac 
pathology raises the question of whether true LVNC, including trabecular 
proliferation, could occur as a compensatory or adaptive mechanism. The 
independent relationship between indices of LV preload and compaction ratio noted 
in the present study further highlight this question.  
Trabecular proliferation could conceivably be a beneficial adaptive 
mechanism for the following reasons. An increase in size or quantity of trabeculae 
would increase the mass and surface area of the LV and hence may improve stroke 
volume. Moreover, LVNC may increase the endocardial surface area and hence 
potentially improve oxygenation via the endocardium [144]; it may assist the impaired 
myocardium by resisting dilatation by tightening the myocardial structure [144]; it may 
increase the muscle mass at the apex, the segment of the LV with the highest 
ejection fraction; and it may enhance viscoelastic properties, which might improve 
ventricular performance in the face of a haemodynamic challenge. 
An increased volume load in neonates and children up until the age of 6 years 
will act on a myocardium that is, because of specialized features of gap junctions and 
fasciae adherents, particularly susceptible to changes in cellular topology and 
remodelling of myocardial architecture [146]. In this time period it is therefore 
plausible that ventricular remodelling, including development of additional trabeculae 
might occur. Indeed, as indicated in chapter 1, in chick embryos, volume loading of 
the heart results in an increased number of trabeculae, which are thinner than normal 
[145]. Against this hypothesis is the finding in the present study of an absence of a 
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relationship between age and trabecular layer thickness. If increased numbers of 
trabeculae developed postnatally in response to a volume load, an age related 
association might be expected, with neonates having fewer trabeculae and older 
children more. Clearly further work is required in patients with VSDs and RHD to 
determine whether early closure of VSDs or repair of the mitral valve, interventions 
that will presumably reduce the volume preloads, will also prevent the development 
of an increased compaction ratio. If noncompaction is part of an early change in life, 
prospective studies will have to be planned to compare changes in the compaction 
ratio in early as opposed to late closure of VSDs or early as opposed to late repair of 
mitral valves. 
 Against the notion that trabecular proliferation might account for an increased 
compaction ratio is that rheumatic fever occurs most frequently in patients between 
10 and 15 years of age [184]. Rarely is rheumatic fever encountered in patients of 5 
years or less. Unlike patients with a VSD, the haemodynamic challenge in this older 
age group would therefore be more likely to produce cellular hypertrophy than 
trabecular proliferation. 
As reviewed in chapter 1 (section 1.5.6), our own observations and 
documented case studies have highlighted temporal changes in the compaction ratio. 
In particular where these occurred in older individuals the finding of prominence of 
the trabecular layer was likely to be due to an enhancement of trabeculae following 
ventricular dilatation and hypertrophy, rather than trabecular proliferation as an 
adaptive mechanism. To answer this question, clearly a formal prospective, 
controlled, intervention study is required to determine whether medically-induced or 
surgically-induced changes in haemodynamic factors may result in regression of the 
compaction ratio.  
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4.10    Potential clinical implications 
 
The scientific literature pertaining to LVNC has been reviewed in previous 
sections and some inconsistencies highlighted. Many controversies remain 
concerning the definitions and diagnosis of this pathology. The compaction ratio is 
the only objective diagnostic criterion, and is in widespread usage to diagnose LVNC. 
I have shown that the compaction ratio may be affected by the volume load of the LV, 
and hence is an unreliable diagnostic criterion for diagnosing this congenital 
malformation (LVNC), in the presence of other cardiac pathologies, congenital or 
acquired. While this study has been confined to patients where LV dilatation was of a 
known aetiology, it is likely that the compaction ratio could also exaggerated in cases 
of dilatation from other causes. In order to avoid unnecessary investigations and 
treatment in patients and their relatives, the presence of an increased compaction 
ratio should be interpreted in context, to avoid over-diagnosis of LVNC. Reappraisal 
of diagnostic criteria is urgently needed.  
Furthermore since the compaction ratio is a measure of the haemodynamic 
load on the LV, and has been shown to be related to mortalities [68] consideration 
should be given to whether it may be a better marker of LV load than other currently 
used criteria. 
4.11    Limitations of the study. 
 
The major limitation of the present study was that it was a cross-sectional and 
not a longitudinal study. Thus, whilst the strong relationship shown between LVEDD, 
LVM and compaction ratio is very likely to be the result of an enhancement in the 
trabeculae due to dilatation and hypertrophy, the effects of congenital and adaptive 
responses cannot be dismissed. Further research in the form of a longitudinal study, 
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following patients before and after interventions would help to clarify these possible 
confounding effects. 
The calculated LVM was derived from m-mode measurements, and has not 
been validated in patients with LVNC. Nevertheless it has been employed in patients 
with both VSDs and RHD. The calculation uses thickness of the muscle at the base 
of the heart and assumes a geometrical shape of the LV which may not be true in the 
presence of substantial thickening of the LV trabecular layer near the apex. 
LV chamber size, wall thicknesses and function were derived using m-mode 
rather than from three-dimensional measurements. However, inaccuracies in m-
mode measurements are more likely to have reduced the sensitivity to detect 
relationships between compaction ratios and internal dimensions or LVM. Hence, if 
anything I have biased the study against an ability to detect these relations. 
The validity of including post operative patients in the group of RHD could be 
queried, the argument being that postoperatively the volume load should have been 
relieved, and therefore they would not be a group representative of chronic volume 
overload. However, most RHD patients post operatively do have residual MR and in 
some cases AR. Furthermore the inclusion of postoperative patients into the 
statistical sample added to the heterogeneity of the group and therefore increased 
the strength of the relationship demonstrated.  Multivariate analysis where these post 
operative patients were excluded was performed, (results not reported here) and 
revealed results consistent with those reported in this study where they were 
included viz. that the primary determinants of the compaction ratio in a multivariate 
analysis were the LVEDD and LVM. The conclusion is that the relationship between 
the compaction ratio and the LVEDD and LVM is a strong relationship, and that the 
inclusion of post operative patients did not affect this outcome. Furthermore the 
greater heterogeneity of the group with the inclusion of postoperative patients 
increased the relevance of the statistical findings. 
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4.12    Conclusions 
 
The present study is the first to formally test the hypothesis that an increased 
compaction ratio can be attributed to volume loading of the LV. I showed that indices 
of LV preload viz. LVMI, LVEDDI, VSD size, and additional shunts, were positively 
and independently associated with the compaction ratio in children and adolescents 
with VSDs and RHD, while LVEF was negatively correlated. This data suggests that 
in congenital and acquired cardiac pathology, the compaction ratio is a function of 
cardiac preload, and thus should be interpreted with caution to avoid over diagnosis 
of LVNC.  
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